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CHAPTER 1 
Introduction 

1 General introduction 
Extracorporeal membrane oxygenation: ECMO 
History 
The development of extracorporeal circulation has had a tremendous effect on 
medicine. Now certain operations in the field of the cardiac and vascular surgery 
became possible and evoluated to routine procedures, first in the US and later also 
in Europe (1). In Nijmegen the first cardiac operation assisted by extracorporeal 
circulation was performed ini963, followed by the first coronary bypass operation 
in The Netherlands in 1968. Ever since the development of the mechanical 
ventilation in the newborn in the 1970's, the neonatal intensive care units were set 
up, giving treatment to critically ill neonates for acquired and congenital diseases. 
In 1976, the first neonatal Extracorporeal Membrane Oxygenation (ECMO) was 
performed by R. Bartlett, in the management of a neonate with respiratory failure 
(2). After this first neonatal procedure, the clinical use of ECMO therapy in 
neonates was facilitated between 1980 and 1990 and became established as an 
effective rescue-therapy. The results improved during the years and according to 
the Registry of the Extracorporeal Life Support Organization, the overall ECMO 
survival rate for neonatal respiratory failure is 86% and for neonatal cardiac failure 
55%. Also other forms of extracorporeal membrane oxygenation were developped 
such as veno-venous ECMO with the great advantage of less vascular damage. 
Supported by a grant of the Ministry of Healthcare, ECMO was introduced in The 
Netherlands at the University Hospital Nijmegen in 1991. Between 1991 and 
2001, 160 patients are treated in Nijmegen with an overall survival of 82.8% 
(range 71.1-95.7). Nowadays, ECMO is an indispensable rescue therapy for 
critically ill newborns. The use of ECMO for children after open-heart surgery, the 
so-called extracorporeal life support is increasing worldwide and also in our center 
since the first case in 1999. In 1987 the Registry of the Extracorporeal Life 
Support Organization started and documented the files of almost all ECMO 
patients from allover the world to collect the data leading to a better understanding 
of the ECMO related complications and providing a unique reference for study, 
results and quality control. 
Definition and ECMO protocol 
Extracorporeal membrane oxygenation is the application of temporary, but 
prolonged gas exchange outside the body and extracorporeal circulation in patients 
with reversible life-threatening situations of cardiac- or pulmonary failure (3,4,5,6). 
During veno-arterial ECMO, the venous blood flow in the right atrium is bypassed 
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through a venous cannula to the ECMO circuit in which a rollerpump supports the 
circulation and a membrane oxygenator will take care for the exchange of carbon 
dioxid and oxygen in the venous blood (see figure 1). 
Figure 1. Scheme of the ECMO circuit 
The fully saturated blood is guided back to the systemic circulation of the infant 
by way of an heat-exchanger to maintain normothermia, and next through the 
artenal cannula positioned on the crossing of the anonymous artery and aortic 
arch In this way a pulmonary and cardiac support as well is performed The 
bladderbox, a small collapsible reservoir with a sensitive microswitch, controles 
the rollerpump in case of decreased circulating volume by switching it off For 
safety reasons, for example air bubbles in the arterial tubes, the bndge is the place 
to remove these air bubbles by clamping the artenal and venous canules and 
performe ECMO over the bridge To support the circulation, usually an ECMO 
flow of 180-200 ml/min/kg body weight will be neccessary for optimal cardiac 
output and oxygen saturation This flow is reached after a gradually step up in 
ECMO flow during the first two hours approximately Because of the risk of 
thrombosis and clotting problems in the extracorporeal circuit all patients are fully 
hepanmzed This anticoagulation therapy is monitored using the activated clotting 
time (ACT) 
Initially a loading dose of heparin 100-150 units/kg bodyweight is administered 
before cannulation, followed by 20-50 U/kg bodyweight based upon an ACT time 
of 220-250 seconds The ACT is monitored every hour using an ACT-momtor 
(HemochronR) 
During ECMO the patient is intubated and ventilated with minimal ventilator 
settings to prevent alveolar collaps (Fi02 30%, respiration rate 16/min, PIP 20-
24 mbar, PEEP 4 mbar) and barotrauma On the contrary to open heart surgery, 
vascular acces is usually reached by a cut down technique in the lateral side of the 
nght neck region The venous cannula is put through the nght jugular vein and the 
artenal cannula is pushed up through the nght common carotic artery Both vessels 
are ligated at the cranial side The cannula position is confirmed by X-ray and by 
ultrasound All patients are sedated routinously using midazolam and fentanyl 
Patients with congenital diaphragmatic hernia are also treated with pancuronium 
during the first 24 hours on bypass and after the surgical repair of the hemia 
Standard antibiotic therapy is administered with ampicillin and gentamycin 
Nutntional support is determined by fluid balance and established by the standard 
parenteral nutrition protocol Patients are nursed in the neonatal intensive care unit 
on an Airshield II CS 90 table 
For the first 48 hours on ECMO in all patients an optimal condition is pursued 
monitored by blood gases, heart rate, blood pressure and oxygen saturation Arterial 
oxygen pressure is maintained between 10 to 13 kPa After 48 hours, weaning 
attempts are undertaken when artenal oxygen pressure is above 13 kPa In that case 
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ECMO flow will be diminished step by step (10-20 ml/hour) until a minimal 
ECMO flow is reached of 50 ml/min. When the clinical condition is stable for 
another 6-8 hour, decannulation is performed and the patient is taken off bypass. 
Clinical observations 
After our first experiences with ECMO in 1991 we observed some important 
clinical symptoms and signs in these patients. First, once on ECMO, a 
stabilisation of pulmonary- and cardiac function was observed leading to a 
better control of hypercapnia, hypoxaemia and oxygen saturation. Especially 
when pulmonary hypertension was "under control" there was a much better 
clinical condition of the patient. This usually happened after 24-48 hours after 
ECMO was started. However during the same first days on ECMO, a tendency 
to fluid retention was observed with severe subcutanous edema allover the skull 
and on the backside of the patient together with oliguria. In the same time with 
these phenomena, the radiological pattern of the chest X-ray showed the 
development of pulmonary opacification known as the typical "white-out 
pattern" that will represent the severe pulmonary edema. In our ECMO center 
all patients were nursed in the neonatal intensive care unit where also treatment 
was performed to preterm neonates. In the observation of all these patients a 
certain overlap was noticed between the premature neonate suffering from an 
important ductal left to right (L-R) shunt on the one side and the ECMO patient 
on the otherside. Both had signs of general edema with or without prerenal 
failure and both had signs of pulmonary edema. When the duct was closed in 
the premature infant, usually polyuria will develope with improvement of the 
clinical condition as well as the radiological picture giving the possibility to 
wean the child from the ventilator. In the ECMO patient, usually there is an 
improvement in the initially worse lungcompliance after the pulmonary edema 
has cleared up and weaning from bypass becomes possible. To illustrate our 
observations, figures 2a and 2b are showing the chest X-ray's during several 
days of patients from both groups. So, in conclusion, we hypothized that 
perhaps an important ductal L-R shunt is created after the pulmonary 
hypertension is succesfully treated with ECMO. Perhaps this ductal L-R shunt 
is on the one side the cause of the pulmonary edema related to the pulmonary 
hypercirculation, and on the other side this ductal shunt is "stealing" from the 
systemic circulation and so contributing to the onset of prerenal failure and 
general edema. 
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Figure 2a 
Radiological findings in the same premature neonate with patent ductus arteriosus before and after 
closure, a = day of birth; b = second day. day of diagnosis: c = third day, day of treatment with 
indomethacin: d = fourth day 
Figure 2b 
Radiological findings in a term neonate before, during and after ECMO. a = day o birth; 
b = after 1 day of ECMO treatment: c = during ECMO weaning: d = before decannulation 
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The observations above have lead to the hypothesis described in the next 
paragraph: 'The aim of the study'. 
The aim of the study 
As mentioned before, there is a great overlap in the clinical picture and in the 
radiological signs of an important ductal L-R shunt in the premature infant and the 
critically ill neonate on ECMO. So what will be the contribution of the ductal L-R 
shunt in the clinical picture and is this shunt responsible for the signs of 
pulmonary overflow and edema during ECMO? When a ductal L-R shunt, on the 
one hand, leads to pulmonary hyperperfusion and pulmonary edema, there has to 
be an important shunt. On the other hand, the amount of blood that is guided 
through the duct to the pulmonary circulation must be "stealed" from the systemic 
circulation, or more appropriate from the bloodflow in the descending aorta and 
even from the cerebral circulation. This will lead to a decrease in the renal 
perfusion possibly leading to general edema as a symptom of prerenal failure. We 
know that ECMO reduces pulmonary hypertension and decreases pulmonary 
resistance. However, is ECMO capable to diminish pulmonary blood pressure so 
early after cannulation that the ductal shunt will reverse? To get a better insight in 
this ductal behaviour and ductal shunt in relation to the consequences for the 
pulmonary- and systemic circulation, we want to answer the following questions. 
- What is the level of pulmonary hypertension initial to ECMO and how is the 
reaction of this hypertension on ECMO therapy? 
- Is the ductus arteriosus patent before and during ECMO and will the shunt 
reverse into the L-R type after pulmonary blood pressure has decreased? 
- In which way the ductal L-R shunt will lead to general and pulmonary edema. 
How is the interaction with ECMO weaning? 
- How is the left ventricular performance during ECMO and what is the 
influence of volume loading parameters. 
- Will it be possible to objectivate and quantify the ductal L-R shunt during 
ECMO to get a better insight into the haemodynamic involvement? 
In the next paragraphs, comprehensive information is presented on the subjects 
who are essential in this manuscript for a better understanding. 
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Pulmonary Hypertension 
All neonates that might be treated with ECMO share "the final common pathway" 
in the onset of a severe pulmonary hypertension and increased pulmonary vascular 
resistance. In this context it is very important to look at the side of the fetal 
circulation. The "persistent pulmonary hypertension of the neonate", PPHN, was 
earlier also described as 'the persistent fetal circulation'. The fetal circulation is 
distinguished from the normal circulation by a patent ductus arteriosus, a patent 
ductus venosus, a foramen ovale and a placental circulation. In the normal 
circulation the pulmonary- and systemic circulations are in series and seperated 
from each other. See figure 3a/b. There are some important characteristics in the 
fetal circulation in comparison to the neonatal circulation. First, before birth there 
is an increased pulmonary vascular resistance. The pulmonary trunk and the major 
pulmonary arteries are very thick-walled, similar to the aorta. 
ductus arteriosus 
vena cava superior 
vena pulmonalis 
crista dividens 
vena pulmonalis 
sphlncer in de 
ductus venosus 
vena cava inferior 
vena umbilicalis 
arteria pulmonalis 
aorta descendens 
arteriae umbilicales 
Figure 3a. 
The fetal circulation 
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arteria 
pulmonalis] 
lìgamentum arteriosum 
vena cava superior 
gesloten 
foramen ovale 
vena cava inferior 
lìgamentum teres hepatis — '* 
Figure 3b. 
The neonatal circulation 
aorta descendens 
arteria vescalis superior 
lìgamentum umbiiicale mediale 
The medial layer is composed of smooth muscle in the smaller pulmonary arteries, 
and in the following branches a thick muscular layer surrounds the whole 
circumference (7). Only approximately 7 % of the cardiac output is determined by 
the pulmonary bloodflow (8). Because of the elevated pulmonary vascular 
resistance, the pulmonary circulation is bypassed by a large patent ductus 
arteriosus with R-L shunt. Now, a substantial amount of venous bloodflow will 
enter the systemic circulation and will join the blood flow from the systemic 
circulation coming from the left ventricle at the transition of the duct to the 
descending aorta. This ductal R-L shunt, will prohibid a raise in arterial oxygen 
tension. Systemic cardiac output is delivered by the right and the left ventricle and 
the fetus is capable in maintaining its normal functions under partial oxygen 
saturations of approximately 65% (8). At the other side, a patent foramen ovale 
will permitt the already saturated blood coming from the placenta by the umbilic 
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vein, entenng the left atnum by an atrial R-L shunt and so contributing to the 
systemic circulation The systemic vascular resistance in the fetus is low and also 
the resistance of the placental circulation The ductus venosus is important in 
connecting the umbilic vein to the fetal heart This circulatory equilibrium is 
maintained during pregnancy until the moment of birth Than transition to the 
postnatal circulation will be essential for normal life This is reached by a 
tremendous increase in the pulmonary circulation First, after birth, the lungs are 
ventilated in a rhytmic way inducing a drop in the pulmonary vascular resistance 
The pulmonary bloodflow will increase rapidly and contnbute to the gas exchange 
in both lungs A nse in arterial oxygen tension will decrease the pulmonary 
vascular resistance and the pulmonary blood pressure more and more A 
remodeling of the pulmonary vascular structure will take place The endothelium 
of the pulmonary vessels plays a crucial role in this proces from fetal to postnatal 
circulation Finally, the normal pulmonary circulation will be marked by a low 
vascular resistance (9) In this process morphological changes such as the 
expansion of the lung and stretching of the pulmonary vessels with remodeling of 
the vascular structure form the underlying basic for the drop in resistance together 
with important humoral factors denved from the pulmonary endothelium and local 
vaso-active substances (10,11) These substances, such as mtnc oxid, bradykinin 
and prostaglandin 12, will rise when the lung begins to ventilate The changes 
above will lead to a tremendous increase in pulmonary bloodflow and 
subsequently an increase in preload for the left ventricle When the ductus 
artenosus is still patent and pulmonary resistance is low, the initial ductal R-L 
shunt will reverse into the L-R shunt After birth, systemic resistance will increase 
after disappearance of the placental circulation This again will increase the ductal 
L-R shunt and the pulmonary circulation So, the ductal L-R shunt will play an 
important role in converting the fetal-transitional circulation into the normal 
circulation before it will finally close The fetus usually will show a right 
ventricular dominant heart that gradually will change into a left ventncular 
dominant heart in the infant by way of the transitional circulation 
(12,13,14,15,16,17) In cntically ill neonates in whom ECMO is performed, the 
conversion of the transitional circulation into the neonatal circulation is disturbed 
Severe respiratory failure due to acquired or congenital disease will form the basic 
that will lead to hypoxia, hypoxaemia, hypercarbia and acidosis (18) These 
disturbances will interact with the changing processes in the pulmonary circulation 
and result in pulmonary vasoconstiction with contraction of the smooth muscle 
layer leading to sustained elevated pulmonary vascular resistance Now the ductal 
L-R shunt is prohibited and the ductal R-L shunt will persist and devellop further, 
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reinforcing hypoxaemia in the postductal circulation of the descending aorta. 
Besides a ductal R-L shunt, an atrial R-L shunt becomes possible during severe 
pulmonary hypertension also contributing to cyanosis and hypoxaemia. This atrial 
R-L shunt at the level of the foramen ovale will occur when the right atrial 
pressure is severely elevated because of high systolic and end-diastolic pressures 
in the right ventricle. Usually, tricuspid valve regurgitation is observed during 
these situations enforcing the atrial R-L shunt (19,20). Circulatory interactions will 
create a deteriorating situation known as persistent pulmonary hypertension of the 
neonate. Before ECMO or therapy with inhaled nitric oxid, the basic treatment 
consisted of administration of non-specific vasodilating drugs such as tolazoline or 
isoprenaline with a systemic hypotension as adverse reaction. Besides vasodilating 
drugs, other supportive treatment was used as oxygen therapy, inotropics or alkali 
therapy. More recently the availability in clinical use of inhaled nitric oxid has 
changed the strategy for treatment of persistent pulmonary hypertension of the 
neonate. The vasodilating effect of inhaled nitric oxid is more specific to the 
pulmonary vessels and has nowadays the highest priority in the strategy of 
pulmonary hypertension treatment (21). Despite the great beneficial effects of this 
treatment there still is the need for ECMO in those patients who are non- or 
bad-responders. 
Before the era of ECMO and inhaled nitric oxid therapy, the prognosis of 
persistent pulmonary hypertension of the neonate was poor (22). Mortality was 
high, up to 70% and morbidity was even higher. The prognosis after ECMO 
treatment has shown a lot of changes until a very acceptable to good prognosis is 
reached for certain specific ECMO patients groups according the ELSO registry 
for neonatal veno-arterial ECMO (23). 
Persistent ductus arteriosus 
In the paragraph above special attention is given to the ductal R-L shunt during 
pulmonary hypertension. However, when pulmonary hypertensive treatment is 
succesfull, a L-R shunt will devellop when the duct remains patent. Than, two 
changes in blood flow are important. First, an increase of pulmonary blood flow 
will occur, leading to pulmonary hyperperfusion. Signs of tachy-dyspnoea, fatique 
and failure to thrive are observed in infants with persistant ductus arteriosus. In 
ECMO patients nursed on the intensive care we usually don't see the classical 
symptoms of an important cardiac L-R shunt. Radiological analysis however will 
show in these patients the signs of cardiac enlargement and pulmonary edema also 
known as the 'typical white-out pattern' (24,25). The lung compliance in these 
patients is low because of the vascular overfilling and tendency to pleural 
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effusions (26). The clinical picture will show signs of high output failure 
especially when the pulmonary bloodflow is twice the systemic bloodflow or more 
(Qp/Qs > 2). At the other side, an important L-R shunt at ductal level together 
with a low pulmonary vascular resistance will create ideal circumstances for a 
stealing circulation in which the blood in the descending aorta will show a 
diastolic run-off in the direction of the pulmonary artery through the patent duct. 
This will lead to a decrease in perfusion of the lower body in which the renal 
perfusion is most important (27,28,29,30). In summary a ductal L-R shunt will 
lead to pulmonary hyperperfusion, a volume-loading to the left atrium and left 
ventricle and a decrease into the perfusion to the body, especially to the 
descending aorta and its continuation (postductal steal). 
Entry diagnosis in relation to ECMO 
Meconium aspiration syndrome (MAS) 
MAS forms with 35-40% the most frequent indication to ECMO (31,23). The 
clinical picture of MAS is characterized by aspiration of meconium-stained-
amniotic-fluid in the perinatal period. The meconium is spread into the periphery 
of the lung by the first breathings of the newborn. In the lung, small airway 
obstruction with atelectasis, hyperinflation and inflammatory pneumonitis will 
develop with respiratory depression, respiratory distress, hypoxia and hypercarbia. 
This situation often is associated with a certain degree of pulmonary hypertension 
and sustained elevation of pulmonary vascular resistance. So the "fetal" circulation 
will persist with signs of cardiac R-L shunting at atrial or ductal level also known 
as persistant pulmonary hypertension in the neonate. In earlier days therapy 
consisted of conventional artificial ventilation with a high percentage of oxygen in 
combination with vasodilating drugs. Nowadays inhaled NO is the first treatment 
of choice in combination with advanced ventilatory strategies such as high 
freguency ventilation. In the patients who are unresponsive to the various 
therapeutic strategies, ECMO will be indicated with a mean ECMO survival of 
94% (23). 
Congenital Diaphragmatic Hernia (CDH) 
With the term CDH usually a posterolateral hemia, type Bochdalek, is pointed out. 
Patients with CDH are characterized by a closing defect of the diaphragm that is 
present with still unknown cause. During the fetal period the "abdominal" viscera 
are present in the pleural cavity attended with a certain degree of pulmonary 
hypoplasia. Both the malformations will soon after birth lead to the respiratory 
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distress and hypoxaemia resulting in persistant pulmonary hypertension of the 
neonate, depending on the gravity of the clinical picture. Similar to the therapy for 
MAS, the therapy for CDH has changed enormously. In the past, CDH was treated 
surgically as soon as possible after birth. Then the strategy was changed 
somewhere between 1980 and 1990. Pre-operative stabilization and delayed 
surgery has become the general approach. In the preoperative period nowadays, 
inhaled NO and ECMO are frequently used to manage the pulmonary hypertension 
and hypoxaemia. A demonstrated Pa02 > 10 kPa in CDH patients prior to ECMO 
is used in our center to select those CDH patients with minimal acceptable 
lungfunction for ECMO. When ECMO is indicated, in our'center the surgical 
correction will be performed during the ECMO coursé after pretreatment of the 
pulmonary hypertension. According to the ELSO registry, the diagnosis CDH 
represents about 22% of ECMO runs with an improving prognosis up to 55% 
survival (23). 
Sepsis neonatorum 
According to the latest ELSO data the diagnosis sepsis is responsible for about 
14% of all neonatal ECMO runs. The survival rate is 76% (23). Usually the patient 
is infected during birth. Mostly group Β streptococcus and E.Coli are involved. 
The clinical picture of a neonatal sepsis is that of multi-organ failure. Free 
bacterial toxins will paralyse the systemic circulation with hypoxaemia and severe 
metabolic acidosis. In this way the cascade of pulmonary hypertension is 
activated. Also direct infectious effects to the pulmonary circulation will lead to 
vasoconstriction of the pulmonary vasculature. 
Respiratory Distress Syndrome 
Respiratory Distress Syndrome is caused by a surfactant deficiency leading to the 
clinical picture of tachy-dyspnoea, grunting expiration and in-drawings at the 
sternum and intercostal space. Usually, these patients are artificial ventilated with 
extra oxygen. Surfactant therapy has changed the impact of this disease but 
sometimes patients are exposed to severe respiratory acidosis and hypoxaemia. 
This situation can lead to elevation of the pulmonary blood pressure and persistent 
pulmonary hypertension of the neonate. In about 8% this diagnosis will form the 
ECMO indication with a fair prognosis concerning survival of 84% (23). 
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Study Outline 
This study was designed to achieve more insight in the circulatory aspects of the 
several ductal shunt types before, during and after ECMO. The consequences of 
these circulatory changes to the left ventricle, the ECMO run and the pulmonary 
circulation are studied. 
Objectives 
- Timing of the responsiveness of the pre-existing pulmonary hypertension to 
ECMO therapy. 
- Determination in time of the turnover of the ductal R-L shunt into the L-R 
shunt in connection to the changes in pulmonary hypertension during ECMO. 
- Measurement of the duration of ductal L-R shunting and observation of the 
spontanous ductal closure. 
- Determination of the clinical impact of a ductal L-R shunt during ECMO. 
- Invasive measurement of the ductal L-R shunt during ECMO and the relation 
to cardiac output and ECMO flow in the animal model. 
- Left ventricular performance during ECMO under several loading conditions. 
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2 Neonatal pulmonary hypertension during extracorporeal 
membrane oxygenation 
Abstract 
Objectives 
This prospective study was designed to monitor severe pulmonary hypertension 
during extracorporeal membrane oxygenation using echo Doppler variables 
Background 
All neonates treated with extracorporeal membrane oxygenation also have severe 
pulmonary hypertension A study which monitors the reaction of the pre-existing 
pulmonary hypertension during extracorporeal oxygenation by frequent sampling 
of those variables related to pulmonary pressure is still lacking Such a study is 
necessary to analyze the complex haemodynamic changes in patients undergoing 
extracorporeal membrane oxygenation 
Method 
In 29 neonates, we estimated pulmonary arterial pressure using peakflow velocity 
of regurgitation across the tricuspid- and pulmonary valve, peakflow velocity of 
shunting across persistent arterial ductus, and systolic time intervals of the right 
ventricle Correlation between the several estimations of pulmonary arterial 
pressure were analysed with the Spearman correlation coefficient 
Results 
Systolic pulmonary arterial pressure measured by the velocity of tricuspid 
regurgitation illustrated severe pulmonary hypertension prior to extracorporeal 
membrane oxygenation (mean 63 mmHg, sd 20) Similar levels for the systolic 
pulmonary arterial pressure could be derived (mean 73 mmHg, sd 17) from ductal 
shunting A fair correlation of 0 76 (P< 0 002) could be demonstrated Pulmonary 
hypertension responded well and quickly to treatment by extracorporeal 
membrane oxygenation, with reductions within 24 hours to mean systolic levels of 
35 mmHg, sd 23 This very early reaction has not previously been demonstrated 
and could be of importance in defining parameters for weaning from 
cardiopulmonary bypass Diastolic pulmonary arterial pressure was investigated 
because of its relation to vascular resistance It proved more difficult to measure 
because of the low incidence of pulmonary regurgitation Derived diastolic 
pressures did not show any good correlations 
Conclusion 
Pulmonary hypertension is well documentated prior to extracorporeal membrane 
oxygenation and responds very quickly to the institution of treatment Ultra sound 
techniques are indicated at the bedsite, and prove useful in monitoring pulmonary 
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blood pressure during the procedure. 
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Introduction 
Severe neonatal pulmonary hypertension due to several causes such as aspiration 
of meconium, congenital diaphragmatic hemia, respiratory distress syndrome or 
neonatal septicaemia is a frequent common pathway for critically ill neonates. This 
clinical situation often fails to respond to standard intensive care, including 
artificial ventilation and pharmacological manipulation of pulmonary vascular 
resistence. Extracorporeal membrane oxygenation has now been used for more 
than 20 years to treat this complication, with good results. According to the 
registry from the Extracorporeal Life Support Organization, overall survival was 
79% ( 1 ) or even higher in selected subgroups (2). Extracorporeal Membrane 
Oxygenation treatment will usually last about one week, during which there are 
several potentially hazardous complications, such as disorders of coagulation, 
hemolysis, renal failure and intracerebral bleeding (3). This study was designed to 
observe the degree of pulmonary hypertension before and during extracorporeal 
membrane oxygenation, using the predicted pressures calculated from echo-
Doppler-derived parameters. Furthermore, we studied the time necessary for 
recovery from pulmonary hypertension. The results provide details about the 
changes in the pulmonary circulation in these neonates, and could be useful 
developing more objective criterions for weaning from cardiac bypass where, 
among other parameters such as pulmonary mechanics and fluid accumulation, 
changes in pulmonary hypertension are equally important. 
Materials and methods 
We studied prospectively 29 critically ill neonates admitted consecutively between 
September 1995 and September 1997. Mean birthweight was 3306 gram (sd 574). 
The group consisted of 10 girls and 19 boys. Mean age at time of cannulation was 
1.8 days (sd 1.3). Extracorporeal oxygenation was indicated because of one of the 
following diagnoses: Aspiration of meconium 16 (55%), congenital diaphragmatic 
hemia 8 (28%), respiratory distress syndrome 1 (3%), neonatal sepsis 4 (14%). All 
patients met the criterions for inclusion and exclusion as shown in Table 1. 
Because of possible rapid changes in the hypertensive pulmonary circulation after 
the initiation of oxygenation, the first ultrasound study was started just prior to 
cannulation and repeated within every 12 hours during the first 60 hours on 
22 
Table 1. Inclusion and exclusion enterions for veno-arterial extracorporeal membrane oxygenation 
Inclusion enterions: 
Alveolar-arterial oxygen difference (AaD02) of more than 600 mmHg during 8 hours. 
AaD02 of more than 605 mmHg during four hours togehter with positive inspiration pressure of 
more than 38 mbar. 
Oxygenation-index of more than > 40 in 3 to 5 consecutive bloodgas analysis. 
Acute deterioration during 2 hours (pH < 7.15 and Pa02 < 40 mmHg). 
No improvement despite maximal therapy during 3 hours. 
Exclusion enterions: 
Birth weight less than 2000 gram. 
Gestational age less than 34 weeks. 
Severe congenital malformations. 
Intracerebral bleeding more than grade 2 according to Papile. 
Coagulation disorders interacting with heparin therapy. 
bypass, and for all following days including the last investigation made within 24 
hours after decannulation. All echocardiographic measurements were made with a 
Toshiba SSH 140 echocardiograph using M-mode-, Doppler- and color-Doppler 
techniques. Interpretation of all echo Doppler variables took place without any 
knowledge of the clinical course of the patient to the observer. 
The following data were collected during this study: 
Echoca rdiog rap h ic measurements 
Systolic time-intervals for left and right ventricles, peak flow velocity of tricuspid 
and pulmonary regurgitation and, systolic peak flow velocity in the pulmonary 
arteries. Ductal shunting was expressed as right-to-left, left-to-right, or bidirectio-
nal, and peak flow velocity of shunting was obtained. 
Pulmonary arterial pressure (systolic and diastolic) was approximated in three 
ways, using the simplified Bernouilli equation (4,5) or the right ventricular systolic 
time interval according to Hirschfeld and colleagues (6). 
• From peak velocity of tricuspid regurgitation according to the equation: Systolic 
pressure right ventricle = 4x(tricuspid insufficiency peak flow velocity)^+central 
venous pressure in mmHg. 
Pulmonary valvar stenosis was excluded so systolic pulmonary arterial pressure 
was assumed to be equal to systolic right ventricular pressure. Diastolic 
pulmonary arterial pressure was estimated as diastolic pressure = 4x(pulmonary 
insufficiency peak flow velocity)^+central venous pressure in mmHg. 
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• From ductal shunting from right-to-left according to the equation systolic 
pulmonary arterial pressure = 4x(systolic ductal peak flow velocity)z+systolic 
bloodpressure and systolic left-to-right shunting to the equation systolic 
pulmonary arterial pressure = systolic blood pressure - 4x (ductal peak flow 
velocity)^ Bidirectional ductal shunting also permitted estimation of diastolic 
pulmonary arterial pressure using the equation diastolic pulmonary arterial 
pressure = diastolic blood pressure - 4(diastolic peak flow velocity)2 In 
bidirectional shunting, the shunt from right-to left occurs in systole, and left-to-
nght shunting is in diastole 
• In addition to the pressure calculations derived using the simplified Bernoulli! 
equation, right ventricular systolic time intervals were also measured and related 
to pulmonary pressures The pre-ejection phase was defined as the time from the 
onset of the QRS-complex to the initial of valvar opening in milliseconds The 
time between initial valvar opening and the end of valvar closure was defined as 
the right ventricular ejection time The ratio of these two variables was used as 
the nght ventricular systolic time interval According to Hirschfeld et al (6), 
diastolic pulmonary arterial pressure may be estimated from this interval as 
diastolic pulmonary arterial pressure = 153 9(systolic time interval)-20 88 
The impact of the observed pulmonary hypertension is best interpretated 
clinically when related to systemic blood pressure Supra-systemic pressure in 
the pulmonary arteries is the worst situation with nght-to-left shunting and 
desaturation On the other hand, a pressure less than half systemic blood 
pressure is reassuring 
Management of patients 
All patients were nursed in a special intensive care room on an AirShield IICS 90 
table Body temperature was maintained between 36 8-37 5 degrees Celsius 
Bloodpressure was obtained from an umbilical arterial line placed with the tip in 
the descending aorta and recorded by a Siemens monitor Central venous pressure 
was measured by an umbilical line with the tip in the nght atrium, and recorded by 
the same monitor in addition to heart rate Pre- and postductal oxygen saturation 
were monitored with a Nellcor pulsoximeter Depending on age, weight gain and 
fluidbalance, minimal prescribed fluid intake was 50 ml/kg, and maximal 150 
ml/kg Standard diuretic therapy was administered using furosemide 8 mg/kg/day 
or 4 mg/kg/day when fluid balance is negative and urinary production was above 3 
ml/kg body weight Mannitol was administered only on indication when oliguria 
was present (mannitol 2 g/kg/day intravenously Antibiotics were routinely 
prescnbed, amoxicillin 100 mg/kg/day and gentamycin 5-7 mg/kg/day Prior to 
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cardio-pulmonary bypass, heart failure or hypotension not due to hypovolaemia 
was treated with intravenous administration of dopamine or dobutamine (5-10 
mcg/kg/min). Pulmonary hypertension was treated with tolazoline, prostacycline, 
magnesiumsulphate, or with inhalation of nitric oxide if necessary. Before the 
extracorporeal oxygenation was started, ventilatory support ranged from standard 
mechanical positive pressure ventilation to high frequency oscillation. During 
bypass, basic mechanical ventilation was supported with minimal ventilator 
settings. Surgical intervention for correction of congenital diaphragmatic hernia 
was performed only after several days of pre-treatment with extracorporeal 
oxygenation, including a weaning period. All patients were sedated during bypass 
using midazolam 0.1-0.3 mg/kg/h and fentanyl 2-10 mcg/kg/h. Pancuronium 0.01-
0.02 mg/kg/h was used in all patients with diaphragmatic hernia 24 hour prior to 
extracorporeal oxygenation, and also for 24 hours after the surgical correction. 
Parental consent was obtained for each patient. The study was approved by the 
local committee on human experimental research. 
Statistical Analysis 
Observations were arranged in intervals before, during and after extracorporeal 
oxygenation. These intervals were 12 hours for the first three days, and 24 hours 
thereafter. The Spearman correlation coefficient was used. P-values of 0.05 or less 
were considered significant. 
Results 
Treatment using extracorporeal membrane oxygenation therapy was succesfull in 
all our 29 neonates. The mean duration of extracorporeal oxygenation was 169.7 
hours (sd 45.6). Of the patients, two died after they had been dismissed from the 
hospital ( 7% mortality). Because of the rapid changes in the echocardiographic 
parameters during the course of treatment, it is important to distinguish these 
observed changes from possible influences produced by changes in bypass. During 
the first 48 hours on bypass, no changes were observed in flow. The mean flow 
was 571ml/min. Attempts to wean were undertaken after 48 hours, with a gradual 
decrease of flow until it was possible to decannulate. 
Systolic echo parameters and approximations of systolic pulmonary arterial 
pressure 
Before attempting to predict pressure from the echo-Doppler parameters, the 
incidence of tricuspid insufficiency, pulmonary insufficiency, ductal shunting and 
related Doppler velocities of peak flow were studied before and during 
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extracorporeal oxygenation. In Table 2, we have listed the incidence of tricuspid 
insufficiency and peak flow velocity before and during bypass. 
During the first 96 hours on bypass, tricuspid insufficiency was found to be 
maximal in 50-60% of all investigated patients. From these values for tricuspid 
insufficiency, we calculated the predicted systolic pulmonary arterial pressure. 
After 96 hours of bypasss, tricuspid insufficiency was less representative for this 
population. Figure 1 shows the derived values for systolic pulmonary arterial 
pressure calculated from the peak velocity of the regurgitant flow in comparison to 
systemic systolic blood pressure. Because of significant changes occuring almost 
immediately after commencement of bypass, only the first 120 hours are presented 
in the figures. Prior to bypass (t=0) all patients with tricuspid insufficiency 
demonstrate pulmonary hypertension (mean 63 mmHg (sd 20). A sharp decline 
was observed even within the first 24 hours on bypass. Values for the systolic 
pulmonary arterial pressure decreased within 24 hours to a mean of 35 mmHg (sd 
23). Looking at the relation to systemic blood pressure, 94% of the patients with 
Table 2. The incidence oftricupid insufficiency and the related peak velocities before and 
during extracorporeal membrane oxygenation 
Number of -patients Peak velocity from the 
Time (h) with tricuspid regurgant tricuspid flow 
Prior to oxygenation 
0-12 
12-24 
24-36 
36-48 
48-60 
60-72 
72-96 
96-120 
120-144 
144-168 
168-192 
192-216 
216-240 
240-264 
264-288 
insufficiency present 
16 
16 
13 
12 
10 
10 
09 
14 
09 
05 
04 
02 
02 
02 
0 
0 
(m/s (sd)) 
3.59 (0.67) 
2.93 (0.26) 
2.45 (0.97) 
2.31(1.35) 
2.52(1.28) 
1.95(0.67) 
2.53 (0.84) 
2.42(1.12) 
2.09 (0.55) 
2.01 (0.52) 
2.67 (0.90) 
2.10(0.43) 
3.12(0.08) 
2.00 (0.08) 
-
_ 
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Figure 1. 
Comparison of mean systolic pulmonary arterial blood pressure with mean systolic systemic 
blood pressure before and during extra corporeal membrane oxygenation treatment. Indicated is 
the mean, continuous line, and ± SD. 
tricuspid insufficiency showed a predicted systolic pulmonary arterial pressure of 
more than half the systemic blood pressure before extracorporeal oxygenation, 
which fall to 33% after 36 hours, illustrating the important drop in pulmonary 
blood pressure very early during bypass. This early and beneficial reaction from 
the pulmonary circulation was achieved within one fifth of the total time spent on 
bypass. Only in one patient (not in the figure) did we observe a rebound 
pulmonary hypertension due to septicaemia occuring after 168 hours on bypass, 
with a predicted systolic pulmonary arterial pressure of 70 mmHg which 
responded well to an increase of bypass flow and administration of antibiotics. In 
all other patients, pulmonary hypertension disappeared without rebound. Looking 
in the subgroup of patients with congenital diaphragmatic hernia, it is remarkable 
that the course of pulmonary hypertension is not essentially different from the rest 
of the investigated patients. After 48 hours on bypass, there is a slight difference, 
with lower values in those with diaphragmatic hernia. Because of small numbers 
( only 8 patients with a hernia ), and a wide range in predicted pressures, we 
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Figure 2. 
Comparison of mean systolic pulmonary arterial pressure in patients with congenital 
diaphragmatic hernia to the other patients of the investigated group. Indicated is the mean, 
continuous line, and ± SD. 
performed no statistical analysis. The data for the patients with diaphragmatic 
hernia are presented in Figure 2. 
Together with the approximated systolic pulmonary arterial pressure predicted 
from the peak velocity of the regurgitant tricuspid flow, the systolic pulmonary 
arterial pressure was also calculated from the systolic shunting from right-to-left 
across the arterial duct, using the equation described before. Before looking at the 
calculated values, we studied the incidence of right-to-left shunting before and 
during bypass. These data are presented in Figure 3. Complete or partial shunting 
from right-to-left was seen in 82% of patients before bypass. In 18%, no ductal 
shunt could be detected. During bypass, this leftward shunting disappeared very 
early in the course, mostly within 24 hours. In most patients a period of shunting 
was found from left to right before closure took place. In about half the patients, 
this rightward shunt was already detected within the first 12 hours on bypass. 
28 
'Λ 
IM) ' 
»Ο 
to • 
ίίι 
M 
Xi. 
I Ï 3 4 1 3 3 4 1 S > 4 1 5 3 4 1 Î 3 4 1 2 3 4 1 5 3 4 I Î 3 4 1 Î 3 4 l»i.inl 
Γ« Ο l i 12 24 2*315 3S 49 4? ÇO 80 ?2 Γ2 86 fi>12l) hour 
L e g e n d s : 1 = Right to Ixft shunt ( • ) , 2 = Bidirectional shunt ( IÜ, 3 = Left to Right shunt ( 0 , 4 = No shunt(Q) 
Figure 3. 
Incidence of ductal shunt before and during extracorporeal membrane oxygenation 
Results for the approximated systolic pulmonary arterial pressure calculated from 
ductal shunting are presented in Table 3. Predicted pressures were slightly higher 
when calculated from ductal shunting in comparison to those derived from the 
Table 3. Values for derived systolic pulmonary arterial pressure calculated f mm the leftward 
ductal shunting peak velocities 
Time (h) 
Before 
0-12 
12-24 
24-36 
36-48 
48-60 
mean pressure 
(mmHg) 
74 
75 
61 
107 
86 
Sd 
17 
18 
5 
9 
7 
Ν 
23 
10 
2 
2 
2 
peak velocity of regurgitant tricuspid flow. Statistical analysis showed a fair 
correlation between predicted systolic pulmonary arterial pressure calculated from 
tricuspid insufficiency and from systolic ductal shunting, with a correlation 
coefficient of 0.76 ( Figure 4- P<0.002). 
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Figure 4. 
Comparison between predicted systolic pulmonary arterial pressure from tricuspid insufficiency 
and ductal shunt peak velocities ( r = 0.76). 
• = predictions from ductal shunt o = predictions from tricuspid insufficiency 
Diastolic variables and approximations of diastolic pulmonary arterial pressure 
The peak velocity of pulmonary insufficiency, diastolic shunting from left to right 
in those with a bidirectional shunt across the arterial duct, and the right ventricular 
systolic time intervals were used as parameters to approximate diastolic pulmonary 
arterial pressure. Pulmonary insufficiency was, in contrast to tricuspid 
insufficiency, observed in so few patients that a derived diastolic pulmonary 
arterial pressure could be calculated only rarely. This was possible in only 3 
patients between 24 and 36 hours after commencement of bypass. Thus the results 
for diastolic pulmonary arterial pressure are limited, especially when compared to 
those derived from tricuspid insufficiency. The individual predictions in the few 
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patients studied during the first 36 hours on bypass showed no signs of severely 
elevated diastolic pulmonary blood pressure. Before extracorporeal oxygenation, 
pulmonary insufficiency was present in only one patient with a peak velocity of 
2.66 m/s predicting an elevated diastolic pulmonary arterial pressure of at least 38 
mmHg. 
Diastolic shunting from left to right across the duct was often seen, especially 
during the first 48 hours on bypass. Between 10 and 67% of all patients showed 
this type of shunt before and during bypass. Data are presented in Table 4. 
Predictions for diastolic pulmonary arterial pressure from these values were much 
higher compared to predictions from the peak velocity of pulmonary insufficiency. 
Statistical analysis is not possible between these predictions because of the very 
Table 4. Values for derived diastolic pulmonary arterial pressure calculated from the 
rightward ductal shunting peak velocities 
Time (h) 
Before 
0-12 
12-24 
24-36 
36-48 
mean pressure 
(mmHg) 
38 
40 
43 
36 
38 
SD 
6 
1 
13 
15 
19 
Ν 
11 
17 
8 
3 
6 
low incidence of pulmonary insufficiency. 
The right ventricular systolic time interval is the third source for calculation of 
diastolic pulmonary arterial pressure. (Figure 5). The standard deviation was high, 
especially when the systolic time interval was elevated, producing extremely high 
predictions for diastolic pulmonary arterial pressure. Prior to extracorporeal 
oxygenation, the mean interval is only slightly elevated, with a mean value of 0.34 
(sd 0.17). A marked increase is seen during the first 24 hours on bypass, with a 
maximum after 12 hours of oxygenation (mean value of 0.73, sd 0.56). After the 
first 12 hours on bypass, there is then a marked decrease leading to normal values 
(0.30/sd 0.12) after 120 hours. 
Comparisons could be made between the predicted diastolic pulmonary arterial 
pressure calculated from ductal left to right shunting and systolic time intervals, 
(Figure 6), but they showed no good correlation before or during extracorporeal 
oxygenation (Spearman correlation coefficient 0.25). 
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Mean right ventricular systolic time interval before and during extracorporeal membrane 
oxygenation Indicated is the mean, continuous line, and ± SD 
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Figure 6 
Values for approximated diastolic pulmonary arterial pressure from the right ventricular systolic 
time interval before and during extracorporeal membrane oxngenation Indicated is the mean, 
continuous line and ± SD) 
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Discussion 
This study informs us about the beneficial effect of extracorporeal membrane 
oxygenation on severe pulmonary hypertension in critically ill neonates monitored 
by non-invasive echo-doppler cardiography in the intensive care unit. The non-
invasive estimation of the pulmonary arterial pressure in children, as well as in 
adults, is well documented. (6-14). In critically ill neonates, the incidence of 
tricuspid insufficiency is high (14) providing the opportunity for longitudinal 
monitoring of pulmonary arterial pressure in special clinical circumstances such as 
extracorporeal membrane oxygenation^ 15,16) In particular, estimations of 
pressure from the speed of tricuspid insufficiency and ductal shunting have been 
shown to be reasonably reliable (10,12,17). During the first 24 hours on bypass, 
we found a very remarkable and early decrease in systolic pulmonary arterial 
pressure. Other authors (15,16) have described this drop in pulmonary hyperten-
sion but much later during the course of bypass. They used intervals of sampling 
much greater than 12 hours. Sometimes a counter current echo-contrast method 
was used (18) rather than Doppler, which is likely to interfere with the pressure 
equilibrium around the persistent arterial duct. According to the registry of the 
Extracorporeal Life Support Organization, the characteristics of the studied 
population could also influence the later decrease in pulmonary hypertension when 
there is a high percentage of patients with diaphragmatic hernia. In our study, we 
could not demonstrate a longer bypass time in patients with such hernias. Because 
of its comfort, and high incidence before and during extracorporeal oxygenation, 
calculations using tricuspid insufficiency are preferable means of predicting 
systolic pulmonary pressure, which is clinically most important. Predictions of 
pressure derived from ductal shunting correlate reasonable well with those 
obtained from tricuspid insufficiency but, in practice, measurements of velocity in 
a patent duct are not always easy to obtain in contrast to the color-doppler ductal 
shunt. Because of the temporary nature of the rightward ductal shunting, only 
limited interpretations and comparisons were possible. Our study reveals a very 
high percentage of partial shunting in this direction (82%) where others (15,16) 
found 67% and 74%. This high percentage of 82% in our study is most likely also 
the result from frequent sampling during the first days on bypass. Estimations of 
diastolic pressure were investigated because of their tighter relation to pulmonary 
vascular resistance. Unfortunately, the incidence of pulmonary insufficiency, and 
ductal diastolic rightward shunting, was very low. During the highest incidence of 
rightward ductal shunting between 12-24 hours on bypass, predictions of pressure 
made from right ventricular systolic time intervals showed markedly increased 
values for diastolic pulmonary arterial pressure. On one hand, rightward ductal 
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shunting can become possible when pulmonary resistance is decreasing but still 
elevated compared to body resistance. On the other hand, accurate maesurement of 
right ventricular systolic time intervals can be very difficult during extracorporeal 
oxygenation because of the poor opening of the pulmonary valve in systole under 
maximal cardio-pulmonary bypass which involves the maesured pre-ejection 
phase, leading to extremely high predictions of pressure. During such bypass, there 
is also the possible risk of cardiac stun and myocardial dysfunction, as reported by 
other studies (15,19). Perhaps, therefore, certain restrictions must be made in 
maesuring right ventricular systolic time intervals during this situation. 
Furthermore a worse ultrasound window in patients with diaphragmatic hemia 
interferes with reliable M-mode echocardiography. Moreover, the gradual decrease 
in pulmonary resistance even in normal neonates could be of influence (20,21), 
and fits with the more gradual decrease in pulmonary vascular resistance 
monitored by right ventricular systolic time intervals during extracorporeal 
oxygenation. Nevertheless, the poor correlation with predicted diastolic pulmonary 
arterial pressures, makes difficult the clinical application of the systolic time 
intervals. In contrast, the systolic pulmonary arterial pressure predicted from echo 
parameters such as tricuspid insufficiency and ductal shunting shows fair 
correlations. This could be used clinically, together with other important clinical 
conditions, to determine the optimal moment for weaning. Together with a 
favourable clinical course, the observed very early reaction of systolic pulmonary 
arterial pressure within 24 hours of oxygenation could, perhaps, allow earlier 
weaning to reduce morbidity and mortality and shorten total time of extracorporeal 
circulation in a substantial number of patients. In a certain, way every neonate on 
extracorporeal oxygenation has to overcome the severe pulmonary hypertension 
prior to and early during the treatment, a period during which the neonate will 
experience a circulatory 'renaissance' with cardio-pulmonary improvement leading 
to the ability to wean from extracorporeal oxygenation and producing better 
conditions for normal life. This so-called circulatory renaissance is best observed 
using serial Doppler echocardiography, with monitoring of the variables which 
permit predictions of pulmonary pressure. 
Doppler echocardiography is therefore an excellent diagnostic tool when used at 
the bedsite in the intensive care unit to monitor severely ill neonates undergoing 
extracorporeal membrane oxygenation. Serial examinations give the opportunity to 
monitor haemodynamic changes notably pulmonary hypertension. Our study has 
demonstrated a very early decrease in pulmonary hypertension during 
oxygenation. The results also give a better understanding of changes in one of 
several complex parameters. Improvement of pulmonary hypertension, in 
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combination with pulmonary recovery, will lead to the possibility to wean from 
cardiopulmonary bypass. The results could provide more objective enterions for 
weaning. More studies will be necessary to analyze these various factors and their 
interrelations in determine the course of extracorporeal membrane oxygenation. 
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3 The influence of ductal L-R shunting during extracorporeal 
membrane oxygenation (ECMO) 
Abstract 
Background/Purpose: To analyze, whether a ductal L-R shunt will prolong ECMO 
in neonates with severe pulmonary hypertension. This study will inform us about 
the onset and termination of a ductal L-R shunt and its potential influences on 
ECMO when pulmonary hypertension decreases during veno-arterial bypass. 
Methods: 29 neonates were monitored during veno-arterial ECMO, using bedside 
echocardiography with 12 hours interval observations. 
Results: Up to 43% of the patients showed this type of shunt already after 12 hours 
on bypass. In total, this type of ductal shunt was found between 12-72 hours on 
ECMO in 62% of the patients. After 72 hours the ductal L-R shunt was no longer 
detected. In 38% of the patients no ductal L-R shunt was found during ECMO. 
Comparisons between these two patient groups revealed a significant longer 
ECMO duration in patients with ductal L-R shunt ( p<0.007). The mean 
prolongation time was 46 hours. Also a significant decrease of LA/Ao ratio (p< 
0.01) was observed during ECMO in the ductus group after closure of the duct, 
illustrating the decrease in volume load for the left heart and lungs. 
Conclusions: We conclude that ductal L-R shunting is related with a substantial 
prolongation of the ECMO course ( mean prolongation of almost two days). We 
suggest that on the one side the ductal L-R shunt will lead to pulmonary • 
hypercirculation and on the other side, post-ductal stealing from the descending 
aortic circulation will dead to prerenal failure. Possibly because of interactions with 
pulmonary- and renal function, a ductal L-R shunt will, among other factors, 
interfere with weaning from ECMO, resulting in a prolonged bypass time. 
Introduction 
In critically ill neonates, veno-arterial ECMO may be indicated usually because of 
severe pulmonary hypertension and hypoxaemia due to R-L shunting at ductal or 
atrial level. Already 12-24 hours after the start of ECMO, an important drop in 
pulmonary hypertension is observed in almost all patients (1,2). As a consequence 
of these changes in pulmonary blood pressure, the pressure-equilibrium around a 
patent ductus arteriosus will change and the pre-existing R-L shunt will reverse 
into a L-R shunt. This ductal L-R shunt will lead to an increase in pulmonary 
blood flow with volume load for the left atrium and left ventricle. The ductal L-R 
shunt will be reinforced during bypass, by the blood flow returning from the aortic 
cannula. Usually the aortic cannula is positioned in the arcus aortae opposite the 
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patent duct. As a result from this ductal L-R shunt, pulmonary hypercirculation 
with pulmonary edema and poor lung compliance will possibly develop on the one 
side established by other authors (3-6). On the other side renal perfusion will 
decrease because of postductal stealing from the blood flow in the descending 
aorta described by others (4,7,8). This stealing could lead to prerenal failure with 
general edema. Depression in renal- and pulmonary function will possibly interfere 
with weaning from cardiopulmonary bypass and will lead to a prolongation of 
ECMO. The aim of this study was to determine the onset and disappearance 
(closure) of ductal L-R shunting during ECMO and to study its clinical impact on 
weaning difficulties. The results of this study will illustrate our hypothesis that 
ductal L-R shunting induced by a drop in pulmonary hypertension, interferes with 
the total bypass time leading to a prolongation on ECMO. 
Methods 
Patient group 
Between September 1995 and September 1997 this study was performed 
prospectively in 29 consecutive critically ill neonates with a mean birth weight of 
3306 gram (sd.574). The observed group consisted of 10 girls and 19 boys. Mean 
age at the time of cannulation was 1.8 day's (sd. 1.3). Treatment with ECMO was 
indicated because of the following diagnoses: Meconium Aspiration Syndrome in 
16 patients (55%), Congenital Diaphragmatic Hernia in eight patients (28%), 
Respiratory Distress Syndrome in one patient (3%) and Neonatal Sepsis in four 
patients (14%). All patients followed the in - or exclusion criteria used in our 
ECMO centre regarding the ELSO standards for ECMO (9). Each patient was 
studied with serial echo Doppler cardiography using a Toshiba SSH 140 echo 
Doppler machine. Because of rapid changes in the pulmonary circulation early 
after initiation of ECMO, the first ultrasound examination was started just prior to 
cannulation and repeated every 12 hours during the first 60 hours on ECMO. 
There-after the ultrasound study was repeated every 24 hours including the last 
examination made within 24 hours after decannulation. Special attention was given 
to the ductal shunt using colour echocardiography to determine the shunt direction 
in suprasternal and parasternal views. Ductal shunt was qualified as R-L, L-R or 
bidirectional. In bidirectional shunt, R-L shunt is in systole and L-R shunt in 
diastole. All ductal shunts were checked using Doppler cardiography where the 
suprasternal window gives the opportunity to measure the blood flow velocity in 
the ductus itself. Ductal L-R shunt was defined as a continuous inflow from the 
aorta into the pulmonary artery together with the matched colour Doppler pattern 
of ductal L-R shunt. To analyse the volume load to the left atrium, we measured 
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the diameter of the aorta and the left atrium to calculate the LA/Ao ratio (10) in 
parasternal long axis view. All patients were nursed in a supine position on a 
Airshield IICS 90 table. Body temperature was maintained between 36.8-37.5 
degrees Celsius. Cannulation for veno-arterial ECMO was performed in the right 
neck region with positioning of the venous canula in the right atrium and the 
arterial canula in the aortic arch. After cannulation, ECMO flow was initiated 
using 180 ml flow/kg/min. Standard sedation and analgesia was given using 
midazolam 0.1-0.3 mg/kg/h and fentanyl 2-10 mcg/kg/h. Antibiotics were 
routinely prescribed, amoxicilline 100 mg/kg and gentamycine 5 mg/kg. 
Conservative treatment of pulmonary hypertension prior to cannulation was 
discontinued during ECMO. In case of hypotension dopamin or dobutamine 5-10 
mcg/kg/min was used after fluid replacement in case of hypovolaemia. Standard 
fluid therapy was administered intravenously. Patients received, depending on age, 
weight gain and fluid balance, between 50-150 ml/kg. Diuretics were given 
routinely with furosemide 8 mg/kg. In case of oliguria, mannitol 2 g/kg. was 
prescribed. Pancuronium 0.01-0.02 mg/kg/h was used in all patients with 
Congenital Diaphragmatic Hemia before ECMO was started and also 24 hours 
after the surgical correction. During ECMO all patients were mechanically 
ventilated using a Babylog 8000 with 'rest'settings of 24 mbar inspiration pressure 
and 4 mbar end-expiratory pressure. Total ECMO duration was defined from the 
onset of cardiopulmonary bypass just after cannulation up to decannulation and 
measured in hours. Weaning attempts were not undertaken within the first 48 hours 
on ECMO. After this period weaning was attempted by lowering cardiopulmonary 
bypass with steps of 20 ml until an ECMO flow of 300 ml/ min was reached 
followed by steps of 10 ml until decannulation at an bypass flow of 50 ml/min. 
Statistical analysis 
The incidence of the several types of ductal shunt is presented in absolute and 
relative numbers. Comparisons between patients groups with and without a ductal 
L-R shunt were made with the two-sample Wilcoxon test. Differences with a p-
value of 0.05 or less were considered significant. The 95% confidence interval was 
calculated. Within group comparisons in LA/Ao ratio before and directly after 
ductal closure were assessed with the one-sample Wilcoxon test. 
Results 
First, we observed the incidence of the several types of ductal shunting as reaction 
on ECMO treatment. It is important to distinguish the observed changes from 
possible influences produced by changes in bypass flow. During the first 48 hours, 
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bypass flow was unchanged with a mean flow of 173 ml/kg/min. After 48 hours on 
ECMO weaning attempts were undertaken as described before. The results are 
presented in Figure 1. Before ECMO is initiated, 43% of the patients showed a 
ductal R-L shunt and 39% a bidirectional type of ductal shunting. So, 82% showed 
the type of ductal shunt that corresponds with the initial existing pulmonary 
hypertension. In this pre-ECMO period, no ductal shunt was detected in 18% of 
the patients. After 12 hours of ECMO treatment we observed a remarkable 
increase in ductal L-R shunt up to 43% of patients. This ductal L-R shunt showed 
a gradually decrease during the following observation periods and was not longer 
detectable after 96 hours on ECMO. On the contrary, the initially observed ductal 
R-L shunt showed a decrease after 12 hours on bypass and reached its lowest 
percentage after 24 hours. The bidirectional type is observed longer, up to 60 
hours in only few patients and its initial course is the same as for the ductal R-L 
shunt. With the disappearance of the several types of ductal shunting, an increase 
is observed in patients up to 62% after 24 hours on bypass, in which no longer a 
ductal shunt is detectable because of spontaneous ductal closure. Finally after 120 
hours on ECMO, spontaneous closure of the duct was found in almost all patients. 
Because the remarkable changes are only present during the first 96 hours of 
ECMO, the figure represents only this interval on ECMO and not the total ECMO 
run. Observations from 96 hours on ECMO showed no interesting changes in 
ductal shunting. 
Next, we analysed the clinical impact of the ductal L-R shunt on the total ECMO 
duration. In 18 patients (62%) a ductal L-R shunt was found during the ECMO 
course while in 11 patients (38%) this shunt was not observed. In this so-called 
ductus group a total ECMO duration was measured of 179 hours (s.d. 46). Patients 
without a ductal L-R shunt showed a total ECMO duration of 133 hours (s.d. 37). 
The mean difference of 46 hours in ECMO duration was statistically significant 
with a p-value <0.007, and a 95% confidence interval of 12-80 hours. So, 
apparently a ductal L-R shunt goes hand in hand with a longer ECMO course. 
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Pre 0-12 12-24 24-36 36-48 48-60 60-72 72-96 
Hours 
L-R shunt R-L&R<->L[ ] No shunt 
Figure I. 
The incidence of the different ductal shunt types before and after ECMO. 
In Table 1 we present the several diagnostic sub-groups and their ECMO duration. 
Table I. Diagnostic subgroups and matched ECMO duration 
Diagnosis 
RDS 
CDH 
MAS 
SEPSIS 
Total 
ductal I-
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
r shunt 
presence number 
1 
0 
6 
2 
7 
2 
2 
18 
11 
ECMO duration 
(mean/ s.d.) 
157 (-) 
170 (36) 
101 (32) 
184(55) 
144 (40) 
200 (59) 
125 (10) 
179 (46) 
133 (37) 
p-value 
ns 
p<0.045 
η s 
ns 
p<0.007 
Comparisons between patients with and without a ductal L-R shunt were possible 
in all subgroups except for Respiratory Distress Syndrome where only one patient 
was diagnosed. All subgroups showed a longer ECMO duration when a ductal L-R 
shunt was observed although time differences were only significant in patients 
with Congenital Diaphragmatic Hernia. In this subgroup a difference of 69 hours 
in ECMO duration was found. Comparisons in ECMO duration in the group of all 
other diagnosis except Congenital Diaphragmatic Hemia showed a longer ECMO 
run in the "ductal"group with a significant difference of 44 hours. This difference, 
with a p-value < 0.03, is even more significant when compared to the significance 
level of ρ < 0.045 in the hernia group. It is also important to mention that in our 
study, patients with Congenital Diaphragmatic Hemia, in general, did not show the 
longest ECMO duration. Finally, we analysed the volume load from a ductal L-R 
shunt for the left atrium during ECMO. Within the patient group with a ductal L-R 
shunt, comparisons were made between the LA/Ao ratio before and after ductal 
closure in 17 patients. These observations are presented in Figure 2. During 
ECMO there is a decrease observed in the mean LA/Ao ratio after ductal closure 
from 1.2 to 1.0. The difference is statistically significant with a p-value < 0.01. 
1,6 
1,4 
1.2 
1 
0,8 
0,6 
Before After 
Figure 2. 
The LA/Ao ratio during ECMO in patients with ductal L-R shunt, before and after 
spontaneous closure 
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Discussion 
This study reveals that a ductal L-R shunt is present in a considerable amount of 
neonates on ECMO This ductal shunt becomes possible when pulmonary 
hypertension falls down during ECMO (1) During this process of circulatory 
changes around a patent ductus arteriosus, the flow from the aortic cannula will 
possibly reinforce the L-R shunt at ductus level This ductal L-R shunt also 
potentially interferes with renal perfusion (4,7 8) by postductal stealing from the 
descending aortic blood flow leading to prerenal failure with oliguria and general 
edema Besides that, Lotze et all demonstrated that the ductal L-R shunt will 
create a situation with pulmonary hyperperfusion and pulmonary edema with great 
impact on lung compliance (3) A lot has been published about the typical 
radiological 'white-out' pattern of the chest X-ray as an expression of pulmonary 
edema, which is present in a high proportion of patients (11-14) Also other factors 
are important in the genesis of pulmonary- and general edema and fluid retention 
during ECMO such as reoxygenation injury (15) In the way described above a 
ductal L-R shunt can reinforce several causes of edema and worsen the ECMO 
course by interfenng with weaning from cardiopulmonary bypass because of a bad 
lung compliance Other authors also found ductal L-R shunts during ECMO but in 
a lower incidence and later in the course (2) Possibly our 12 hours examination 
interval is more sensitive in detecting ductal shunts However, this study reveals 
the prolonging effect from a ductal L-R shunt on ECMO with almost 48 hours To 
our opinion this ductus-associated prolongation is of clinical importance because 
of the risks associated with ECMO to which a patient is exposed Only few studies 
report the reversal m ductal shunting but without granting great clinical impact (2) 
Although the numbers of the vanous diagnostic subsets are small, it is remarkable 
that patients with Congenital Diaphragmatic Hemia did not show the longest 
ECMO duration, which is usually the case according to the ELSO data (9) To our 
opinion a longer ECMO course is more likely to be the effect of ductal L-R 
shunting than a result from the diagnosis Congenital Diaphragmatic Hernia 
Unfortunately, there are no other publications about this specific issue Concerning 
the volume loading to the left heart by a ductal L-R shunt, it is documented (10) 
that LA/Ao is influenced by a ductal L-R shunt However, during ECMO it is not 
earlier demonstrated During cardiopulmonary bypass for ECMO, antegrade 
pulmonary blood flow is diminished so, preload to the left heart is also diminished 
and therefore the LA diameter The reinfused blood flow into the ascending aorta 
from the aortic cannula could alter the aortic diameter So during bypass LA 
diameter is probably smaller and aortic diameter larger Therefore the LA/Ao ratio 
will not be much increased but is useful in monitoring changes in the left atrial 
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diameter especially when bypass flow is unchanged. When ECMO creates a drop 
in pulmonary hypertension and subsequently a ductal L-R shunt, pulmonary blood 
flow is likely to be increased by the continuous ductal inflow. During ECMO it is 
therefore possible that the LA/Ao ratio will increase and subsequently will 
decrease again after spontaneous closure of the ductus. The observed changes in 
LA/Ao are mostly detected very early in the ECMO course when bypass flow is 
still unchanged or will show only very small changes. Other authors measured also 
diameters of the left atrium and aorta before during and after ECMO. They 
observed no significant changes in LA/Ao ratio. However, observation intervals in 
their study were much larger compared to our study. Besides that, they made no 
difference between patients with and without a ductal L-R shunt (2). The results of 
our study indicate that the ductal shunt deserves much more attention during 
ECMO and more studies are neccesary to analyze the effect from the ductal L-R 
shunt and its relevance among other factors, on weaning variables. If we were able 
to control the ductal L-R shunt during ECMO after pulmonary hypertension is 
treated efficaciously, possible reduction in ECMO duration could be realizable 
with lowering risk for mortality and morbidity. 
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4 Measurement of the ductal L-R shunt during extracorporeal 
membrane oxygenation in the lamb 
Abstract 
In neonates, initially a ductal shunt is often observed during ECMO Depending to 
the degree of pulmonary hypertension in these patients the ductal shunt will be 
R-L, L-R or bidirectional A ductal L-R shunt will possibly lead to pulmonary 
hyperperfusion and interact with ECMO weaning The aim of this study was to 
give more insight in this ductal L-R shunting during ECMO 
In seven lambs, closure of the duct was prohibited by infiltration of the ductal wall 
with formaline 10% Secondary, this patent duct could be closed using a 
vesselloop around the duct Ultrasound flowprobes were installed aroud the 
pulmonary artery, ascending aorta and around the ECMO circulation tube Right 
and left ventricular output and ECMO circulating volume were measured Ductus 
flow was defined as Qduct L-R = Qao - Qpa and Qduct R-L = Qpa - Qao 
In 6 of 7 lambs a ductal L-R shunt was observed with a mean shunt of 44% (range 
11-79) of left ventricular output (Qduct L-R/Qao) Companson to ECMO flow 
(Qduct L-R/Qecmo) revealed a mean shunt of 91% (range 15-230) When 
compared to the total circulating volume (Qpa+Qecmo), the mean ductal L-R 
shunt showed a percentage of 51% (range 7-142%) 
During veno-artenal ECMO mostly a ductal L-R shunt is observed in the lamb 
This ductal shunt is haemodynamically important with a mean shunt of 44% of 
left ventricular output When the ductal L-R shunt is compared to the total 
circulating volume a mean shunt of 51 % is calculated Because of this important 
L-R shunt, interference with pulmonary- and systemic perfusion such as renal 
perfusion is to be expected 
Introduction 
Extracorporeal membrane oxygenation is used for many years (1) in critically ill 
neonates with severe pulmonary hypertension due to cardiorespiratory failure 
secondary to meconium aspiration syndrome, congenital diaphragmatic hernia , 
neonatal sepsis or persistent pulmonary hypertension of the neonate In the clinical 
situation prior to ECMO, the duct is mostly patent with R-L shunting due to 
pulmonary hypertension (2,3) During ECMO, a drop in pulmonary hypertension 
is observed , usually early in the course (2,3) 
The decrease in pulmonary blood pressure and pulmonary resistance will create 
ideal circumstances for a significant ductal L-R shunt in case the duct is still 
patent From the clinical picture, there are characteristic signs and symptoms in the 
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neonate during the ECMO course such as general edema, pulmonary edema , 
decreased lung compliance and a typical white-out pattern on the chest X-ray 
(4,5). The question is whether a ductal L-R shunt plays, among other factors (6), 
an important role in this clinical picture. Therefore it is important to quantify this 
ductal L-R shunt during ECMO and observe its relation to cardiac output and 
ECMO flow. 
Materials and methods 
Fetal animal preparations 
In this study, all animals were taken care of according to the rules of Good 
Laboratory Practice including water- and food supply. Surgical and experimental 
procedures were approved by the Ethical Commitee on Animal Research of the 
University of Nijmegen. The lamb was selected for this study because of its close 
relation to physiological aspects of the circulation in the human infant (7), and also 
because of experience with the ECMO model in the lamb. Seven mixed breed 
ewes were operated under general anaesthesia around 140 days of gestation (term 
147 days). Anaesthesia was induced with pentobarbital 30 mg/kg intravenously 
and maintained with 2 % enflurane in a 1:1 mixture of nitrous oxide and oxygen 
administered by mechanical ventilation (Engstrom ER 300 respirator, Stockholm, 
Sweden ). Body temperature was maintained by means of a thermostatic pad. 
Heart rate was monitored by an ECG monitor. After shaving and desinfecting the 
abdominal skin, a laparotomy was performed by paramedian incision. The 
peritoneum was opened and the uterus was mobilized and covered with warm 
soaked gauzes. By palpating the fetal lamb and under accurate haemostasis, 
hysterotomy was performed around the fetal left shoulder followed by partial 
delivery of the upper part of the fetal lamb. After positioning for a left lateral 
thoracotomy in the fourth intercostal space, the fetal lamb was covered with warm 
soaked gauzes. Using a spatula, the left lung was kept aside and the great vessels 
including the duct were identified and bridled using vessel loops. Now the 
ascending aorta, pulmonary artery and the duct were trimmed from their adjacent 
tissue. The ductal wall was infiltrated without entering the ductal lumen to provide 
patency, with formaline 10 %, colored with a few drops of sterile methyleen blue, 
according to the technique described by Rudolph et al (8). 
Approximately the total length of the duct was infiltrated. This was checked by the 
blue colored ductal wall. The subadventitial infiltration was performed circular as 
much as was possible with special attention for the posterior part. Next a vessel 
loop was positioned around the duct without narrowing its lumen. The ends of the 
vessel loops were put into a sheath and fixed with a clamp. After this preparation. 
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the patent duct could easily be closed from outside the thorax by pulling the 
vesselloops out of the sheath. Flow probes (Transonic cardiac output A probes / 
Transonic Systems Inc. Ithaca NY, USA) were installed around the ascending aorta 
and pulmonary artery both just above the arterial valves. Probes ten or twelve 
millimeters of diameter were used depending of the artery diameter. Both the leads 
of the probes and the sheath containing the vessel loop around the duct were 
exteriorized from the thorax. The leads of the flow probes were connected with a 
Transonic Medical flowmeter HT 207 (Transonic Systems Inc. Ithaca NY, USA.). 
The thorax was closed in layers. 
Flow measurement and calculations 
To measure the ductal bloodflow we defined the total systemic circulation (Qtot) 
as the summation of ECMO flow (Qecmo) and pulmonary artery flow (Qpa). In 
formula, Qtot = Qecmo + Qpa. In case of ductal L-R shunting, the total systemic 
circulation is also defined as ECMO flow together with ascending aorta flow 
minus the flow in the ductal shunt (Qduct). In formula, Qtot = Qecmo + Q ao -
Qduct. Both equations now define the total systemic circulating volume: Qtot = 
Qecmo + Qpa = Qecmo + Qao - Qduct. Thus, Qduct = Qao - Qpa in case of a 
ductal L-R shunt and Qduct = Qpa - Qao in case of R-L shunt. Both blood flows 
in the pulmonary artery and in the ascending aorta are maesured simultaneously 
and together with the ECMO flow, so the ductal L-R shunt is easily calculated 
from the equations above in ml/min. In this calculation, coronary perfusion and 
possible atrial shunting is left out of consideration. Comparison of the ductal L-R 
shunt to aortic flow ( Qao ), ECMO flow ( Qecmo ) or total systemic circulation 
(Qpa + Qecmo) will provide the possibility to determine the haemodynamic 
importancy. 
ECMO surgery and cannulation 
After the fetal preparations as described above, the fetal lamb was orotracheal 
intubated and mechanically ventilated using a Babylog 8000 (Draeger, Lübeck, 
Germany). The umbilical cord was ligated and the lamb was placed over to the 
ECMO table. Catheters were inserted through the femoral artery and vein and the 
tips were placed respectively in the abdominal aorta for bloodsampling and 
monitoring of the systemic blood pressure, and in the inferior cavai vein for 
administration of fluids and medication. Anesthesia was induced using midazolam 
0.2 mg/kg, fentanyl 10 ug/kg and pancuronium 0.1 mg/kg and maintained with 
midazolam 0.2 mg/kg/h, fentanyl 2-5 mg/kg/h and pancuronium 0.02 mg/kg/h. 
Standard veno-arterial ECMO was performed by cannulating the right common 
55 
carotid artery and the jugular vein using a 10 and 12 french cannula respectively. 
The tip of the arterial cannula was positioned in the brachiocephalic trunk and that 
of the venous cannula in the right atrium. During ECMO heparin was administered 
intravenously and monitored using the activated clotting time (ACT: 200-250 
sec). ECMO flow was measured by a Transonic flow probe around the arterial 
ECMO tube connected with a Transonic Medical volume flowmeter HT 107. ECG 
was monitored during the experiment using needle elektrodes connected to a 
Hewlett Packard 78330A monitor (Hewlett Packard, Boeblingen Germany). Rectal 
temperature was kept between 38.5-39 degrees Celsius with a servo controlled 
heating mattress. 
Experimental protocol 
After all preparations, the lambs were stabilized. Ventilator settings were adjusted 
to maintain normoxemia: arterial oxygen saturation > 90%, arterial partial pressure 
of oxygen > 10 kPa and arterial partial pressure of carbon dioxide at 3.6-6.4 kPa. 
Priming of the ECMO system was carried out by using sheeps donor blood in 
combination with gelofusine . After starting ECMO, the flow rate was increased 
gradually over several minutes until further increasement was impossible due to 
limitations of the backflow in the venous cannula. The mean ECMO flow obtained 
was 90 ml/kg/min (range 73-118 ml/kg/min). Mean body weight of the lambs was 
4.3 kg (range 3.1-5.1). Once stabilized, ECMO was continued for two hours 
during which flows were measured according to our protocol. Than the duct was 
closed using the mechanism described before. Figure 1 is demonstrating an 
overview off all measured flows and calculated ductal L-R flow during an 
experiment. All flows were recorded in a data acquisition system (personal 
computer with data aquisition software, POLY (R), Inspector Research System, 
Amsterdam, The Netherlands) together with heart rate and blood pressure. After 
finishing the experiment, the lamb was terminated by an overdose of pentobarbital. 
Autopsy was performed with special attention for the patency of the duct and its 
mechanical closure system. The heart was inspected using the sequential analysis 
for detecting congenital heart disease. 
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Figure I. Overview of measured flows during an experiment and calculated ductal L-R flow 
—*: closure of ductus arteriosus 
Data analysis 
All data were recorded with a frequency of 100 Hz. Mean flow data were 
calculated over the interval one hour before closing the duct and presented as the 
mean and its range. Data analysis 
Mean ductal L-R shunt was calculated and also expressed as part of the left 
ventricular cardiac output, ECMO flow and total systemic circulating volume. 
Results 
Tabel 1 presents the flow data observed during all the experiments. A ductal L-R 
shunt could be calculated in 6 of 7 experiments. In one case a ductal R-L shunt 
was observed and calculated as 324 ml/min. In all lambs with a ductal L-R shunt, 
Table 1. Measured flow in ascending aorta, pulmonary artery and ECMO-circuit with 
calculated ductal shunt 
experiment 
Qao (ml/min) 
Qpa ml/min 
Qecmo ml/min 
Q L-R ml/min 
Q R-L ml/min 
R-L 
no: 1 
582 
906 
415 
... 
324 
2 
1145 
620 
506 
525 
3 
468 
410 
400 
58 
4 
1047 
223 
359 
824 
L-R 
5 
1354 
1201 
365 
153 
6 
615 
215 
392 
400 
7 
328 
166 
312 
162 
Mean 
791 
534 
393 
354 
... 
Range 
328-1354 
166-1201 
312-506 
58-824 
... 
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a mean shunt was calculated of 354 ml/min (58-824 ml.) corresponding to 82 
ml/min/kg bodyweight. In Tabel 2, the flowratio of the ductal L-R shunt in 
comparison to the several output volumes, namely left ventricular cardiac output 
(Qao), ECMO flow (Qecmo) and total circulating volume (Qtot) is showed. 
Table 2. Flow ratio between ductal L-R shunt and respectively left ventricular output, 
ECMO flow and total systemic circulation 
R-L _ _ _ L - R _ _ 
experiment no: 1 2 3 4 5 6 7 Mean Range 
QL^R/QaoT^c) —— — 4 6 — 12^ ~79 "Tl ~ 6 5 ~ 4 9 " 44 11-79 
Q L-R/Qecmo (%) — 104 15 230 42 102 52 91 15-230 
QL-R/Qtot(%) — 47 7 142 10 66 34 51 7-142 
(= Qpa + Qecmo) 
Fortyfour percent of the left ventricular cardiac output is presented by the ductal 
L-R shunt. In comparison to the ECMO flow, a flowratio of 91% was 
demonstrated when the flow of the ductal L-R shunt was compared to the ECMO 
flow. Looking at the total systemic circulation, the ductal L-R shunt forms 51% 
part of the total circulating volume. In 5 lambs, the ductal flow approximated to 
zero after closure using the vesselloop. In two lambs a residual ductal shunt 
persisted after closure. At autopsy, we discovered in these lambs once a small 
perforation in the ductal wall and once a not proper totally closed duct 
demonstrating a residual diameter of 2-3 mm. In all other experiments the duct 
was found closed at autopsy with the vesselloop thight around the duct. Not one of 
the lambs demonstrated signs of congenital heart disease at autopsy. 
Discussion 
From the results of our study, we can conclude that in the lamb a large and 
significant ductal L-R shunt during ECMO is noticed with a mean percentage of 
44 % of left ventricular cardiac output or 51 % compared to the total systemic 
circulation. In comparison to L-R shunts in neonates or infants because of 
congenital heart disease such as ventricular septal defect, similar percentages as 
observed in our study would be haemodynamically important and will usually give 
way to (surgical) treatment (9). A significant ductal shunt will give support to the 
onset of pulmonary hypercirculation and decreased renal circulation as described 
by E.I. Wallgren in infants and by Clyman in lambs (10,11). ECMO will facilitate 
this pulmonary hypercirculation because of its beneficial effect on pulmonary 
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resistance and pulmonary hypertension. In this study we measured bloodflow in 
neonatal lambs immediately after birth when still a certain level of pulmonary 
hypertension is present. In this way we tried to imitate the pulmonary hypertensive 
state of neonates on ECMO. In one experiment, we observed a ductal R-L shunt 
as an expression of pulmonary hypertension. This experiment was complicated by 
severe systemic hypotension when ECMO was initiated. The administration of 
large doses of adrenalin and sheep blood was necessary to treat this hypotension, 
resulting in ventricular fibrillation. Defibrillation and a forced step up in ECMO 
flow was performed and succesfull. After this asphyctic period we suggest that 
acidosis and pulmonary hypertension was involved, resulting in a ductal R-L 
shunt. Of course, ECMO should be succesfull in treating this pulmonary 
hypertension but usually not capable in reversing the ductal shunt within the two 
hours of our experiment. In neonates, this occurs usually within 12-24 hours after 
ECMO is started (3). 
Anyhow, the demonstrated significant ductal L-R shunt during ECMO will give 
support to a pulmonary hypercirculation with pulmonary edema at the one side. In 
neonates on ECMO, severe lung compliance disturbances (12) and the so-called 
radiographic "white-out" pattern of the lungs (13) could be explained from this 
ductal shunt. At the other side, a mean ductal L-R shunt of 44% of left ventricular 
cardiac output is important enough to interfere with the perfusion to the 
descending aorta and so to the renal perfusion (10,11). In this way some degree of 
renal hypoperfusion with general edema as consequence, is acceptable and also 
explicable from the ductal L-R phase during ECMO. Many authors did 
demonstrate the ductal L-R shunt during bypass in neonates (1,2, 14). Also other 
authors quantified a ductal L-R shunt mostly in the animal experiment (15). 
However, no other studies quantified the ductal L-R shunt during ECMO. Our 
results concerning the significant ductal L-R shunt agree with the ductal shunt data 
published by Clyman (11) and by Baylen (15). Perhaps their measurements in 
preterm lambs treated with surfactant could explain some differences in 
comparison to our study. We measured the ductal L-R shunt about two hours after 
birth, usually a period with still a certain degree of pulmonary hypertension and 
elevated pulmonary resistance. In comparison to neonates, our animal 
experimental situation is unfavourable for the development of a progressive L-R 
shunt because of the limited time on ECMO. And yet, we measured already such 
an important L-R shunt. Hypothetically, inforcement of the ductal shunt could be 
possible by the flow from the aortic canula which returns from the pump into the 
aortic arch not far from the origin of the duct, especially when pulmonary 
resistance drops and bypass is maintained for several days. 
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At the other side, bloodpressure during veno-arterial bypass is usually less 
pulsatile, possibly leading to mitigation of the inforcing effects described above. 
Much more studies are necessary to analyse the different side-effects of the ductal 
L-R shunt in relation to other organ perfusion and function during ECMO. 
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CHAPTER 5 
Ductal dependent changes in left ventricular 
dimensions and fractional shortening in neonates 
undergoing veno-arterial 
extracorporeal membrane oxygenation 
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5 Ductal dependent changes in left ventricular dimensions and 
fractional shortening in neonates undergoing veno-arterial 
extracorporeal membrane oxygenation 
Abstract 
The aim of this study was to analyse left ventricular fractional shortening during 
Extra Corporeal Membrane Oxygenation under the influence of changing volume 
loading conditions induced by a ductal left to right shunt In all patients the 
fractional shortening was observed before, during and after bypass together with 
the presence or absence of a ductal left to right shunt, using echocardiography 
During membrane oxygenation there was a significant decrease in fractional 
shortening (p < 0 001 ) Fractional shortening before and after membrane 
oxygenation showed no difference A greater decrease in fractional shortening was 
observed in the group with a ductal left to right shunt, compared to patients 
without this ductal shunt (p < 0 006) The diastolic diameter of the left ventricle 
showed a significant increase in those patients with a ductal left to right shunt 
during the membrane oxygenation More-over, patients demonstrating a ductal left 
to right shunt during the course of membrane oxygenation, showed significant 
more frequently (p <0 05) a very severe decreased fractional shortening (fractional 
shortening lower than 10%) 
Conclusion During veno-arterial Extracorporeal Membrane Oxygenation, an 
important decrease in left ventricular fractional shortening is observed A ductal 
left to right shunt during bypass will increase the loading conditions to the left 
ventricle illustrated by a significant increase in diastolic left ventricular dimension 
in ductus patients However, despite the volume loading effects of a ductal left to 
right shunt during bypass, the decrease in fractional shortening is significantly 
more pronounced for these patients So during membrane oxygenation the volume 
loading effects from a ductal left to right shunt cannot prevent a decrease in left 
ventricular fractional shortening 
Introduction 
Cardiac performance is usually determined by preload, afterload, contractility and 
heart rate (1) Recently the synchronous contraction of the ventricles is considered 
as an important factor too (2) During veno-artenal extracorporeal membrane 
oxygenation, important changes in preload are observed (3) Because of the 
drainage from the right atrium to the pump, the preload for the right ventricle is 
decreased and because of the bypassed pulmonary circulation also the preload for 
the left ventricle will be decreased In contrary to heart surgery, the heart during 
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extracorporeal membrane oxygenation is not empty Most ultrasound observations 
during extracorporeal oxygenation will show a non-collapsed heart even at high 
pump-flow rates (4) Usually flow rates of 180-200 ml/kg/min have been used 
almost equal to the normal neonatal cardiac output (5) Changes in loading 
conditions are frequently attributed to alterations in left ventricular dimensions and 
fractional shortening during bypass (6,7) Mostly after 24-48 hours of bypass, a 
significant decrease in fractional shortening is observed During the same phase of 
the bypass course, a ductal left to right shunt is observed in a considerable amount 
of neonates (7,8,9) This ductal shunt will increase the pulmonary perfusion and 
thus increase the preload to the left heart In this study we were interested in 
intracardiac volume changes induced by a ductal left to right shunt and its 
consequences for the left ventricular dimensions and fractional shortening At the 
one side, because of an increase in loading conditions to the left ventricle, an 
increase in fractional shortening could be expected According to the literature this 
ductal left to right shunt could perhaps protect the left ventricle against a decrease 
in fractional shortening (10) At the other side, the stressed myocardium in this 
phase of the bypass run will possibly be incapable to tolerate the ductus induced 
increased loading conditions shortly after membrane oxygenation is started 
Methods 
Consecutively, twenty nine patients were studied prospectively and met the 
standard criteria ( 11 ) for Extracorporeal Membrane Oxygenation They were all 
treated with veno-artenal membrane oxygenation also according to the standard of 
the Extracorporeal Life Support Organization The group of twenty nine neonates 
consisted of ten girls and nineteen boys Mean birth weight was 3306 gram (sd 
574) Membrane oxygenation was indicated because of the following diagnoses 
Meconium aspiration syndrome in sixteen (55%), congenital diaphragmatic hernia 
in eight (28%) respiratory distress syndrome in one (3%) and neonatal sepsis in 
four (14%) Mean age at time of cannulation was 1 8 days (sd 1 3) Cardiac studies 
were performed with a Toshiba SSH 140 echocardiograph using sector-and M-
mode echocardiography with calculation of the fractional shortening in the 
parasternal long axis view Fractional shortening was calculated as the diastolic 
dimension of the left ventricle minus the systolic dimension of the left ventricle 
divided by the diastolic dimension of the left ventricle, multiplied by 100 and 
expressed as a percentage (12) All patients were examined just before 
cannulation, every 12 hours on bypass during the first 60 hours and all following 
days including the last investigation made within 24 hours after decannulation 
The presence of a patent ductus arteriosus with a left to right shunt was diagnosed 
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using color-and Doppler echocardiography in the suprasternal and parasternal 
views A ductal left to right shunt was defined as a continous inflow in the 
pulmonary artery from the aortic arch Interpretation of all echo Doppler variables 
took place without any knowledge of the clinical course of the patient to the 
observer 
Management of patients 
All patients were nursed in a special intensive care room on an AirShield IICS 90 
table Body temperature was maintained between 36 8 and 37 5 degrees Celsius 
Blood pressure was obtained from an umbilical arterial line placed with the tip in 
the descending aorta and recorded by a neonatal monitor (HP 78801 B) Central 
venous pressure was measured by an umbilical line with the tip in the right atrium, 
and recorded by the same monitor in addition to the heart rate Pre- and postductal 
oxygen saturation were monitored with a Nellcor pulsoximeter Depending on age, 
weight gain and fluid balance the prescribed fluid intake was at least 50 ml/kg, and 
maximal 150 ml/kg Standard diuretic therapy was administered using furosemide 
4-8 mg/kg/day depending on fluid balance and urinary production Antibiotics 
were routinely prescribed, amoxicillin 100 mg/kg/day and gentamycine 5-7 
mg/kg/day Prior to cardio-pulmonary bypass, heart failure or hypotension not due 
to hypovolaemia were treated with intravenous administration of dopamine or 
dobutamine ( 5-20 mcg/kg/min) Pulmonary hypertension was treated with 
vasodilating drugs including inhalation of nitric oxide Before the extracorporeal 
oxygenation was started, ventilatory support ranged from standard mechanical 
positive pressure ventilation to high frequency oscillation During bypass, basic 
mechanical ventilation was maintained with minimal ventilator settings Surgical 
intervention for correction of congenital diaphragmatic hemia was performed only 
after adequate oxygenation could be obtained with bypass flow weaned to 50 
ml/mm All patients were sedated during bypass using midazolam 0 1-03 mg/kg/h 
and fentanyl 2-10 mcg/kg/h Pancuronium 0 01- 0 02 mg/kg/h was used in all 
patients with diaphragmatic hernia 24 hours after initiation of extracorporeal 
oxygenation, and also for 24 hour after the surgical correction Parental consent 
was obtained for each patient The study was approved by the local committee on 
human experimental research This study was financially supported by the Dutch 
Heart Foundation (grant no 94 023 ) 
Statistical analysis 
The diastolic and systolic left ventricular dimensions and the fractional shortening 
in all patients were monitored before, during and after extracorporeal oxygenation 
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Figuur IA and IB: Variations in mean diastolic (IA) and systolic (IB) lefi ventricular 
dimensions during extracorporeal membrane oxygenation in all patients. (Ddlv = diastolic 
dimension of the left ventricle, dslv = systolic dimension of the left ventricle). 
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These observations were made as part of a another study published earlier (8) 
Observations especially made to analyse the influence of a ductal left to right 
shunt were selected as, before the start of bypass, 24-36 hours on bypass and 
within 24 hours after decannulation Data are presented as mean and range 
Because of the still unchanged maximal bypass flow at 24-36 hours after start of 
the extracorporeal membrane oxygenation together with a high prevalence of a 
ductal left to right shunt (8 9) , the observation was chosen at 24-36 hours on 
bypass 
Patients were grouped according to the presence of a ductal left to right shunt, 24-
36 hours after extracorporeal membrane oxygenation has started, as the 
"ductus"group and the "non-ductus"group The differences in left ventricular 
diameter and the fractional shortening before, during and after bypass were 
computed and assessed with the Wilcoxon test (signed rank test) in all patients and 
with the Wilcoxon test (rank sum test) for differences between groups P-values of 
0 05 or less were considered significant 
Results 
Results concerning variations in left ventricular dimensions and fractional 
shortening in all patients 
The measured values of left ventricular dimensions and fractional shortening, during 
bypass are showed in figure 1 A/B and figure 2 Bypass flow is unchanged during the 
first 48 hours on membrane oxygenation because no weaning attempts were 
undertaken Therefore the first part of the figures 1 A/B and 2 represents all patients 
in the same phase of extracorporeal oxygenation under full bypass flow However, 
due to the different clinical course of extracorporeal membrane oxygenation, the 
second part of the figures 1 A/B and 2 is difficult to analyze because patients will 
show a lot of differences among themselves in the weaning process After 
decannulation all patients are again comparable between themselves in the same way 
as before bypass and during the first 48 hours on bypass 
Looking at the left ventricle(table 1 and 2), the mean diastolic and systolic left 
ventncular dimensions before bypass were small and approaching the fifth percentile 
when compared to the normal values for left ventncular dimensions in children 
(13,14) However, during the first 48 hours of membrane oxygenation, despite the 
unchanged high bypass flow, an significant increase in diastolic and systolic 
diameter was observed (p < 0 02, ρ < 0 001) in all patients The systolic diameter 
will show a decrease dunng the bypass course After membrane oxygenation is 
stopped, the left ventncular dimensions are still small compared to normal 
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Figuur 2: Variations in mean lefi ventricular fractional shortening during extracorporeal 
membrane oxygenation in all patients, (sf = fractional shortening). 
Looking at the fractional shortening, a normal mean fraction of 36% (sd 11) was 
measured before bypass. After extracorporeal oxygenation was initiated, mean 
fractional shortening decreased to 20% (sd 11) and thus demonstrated a significant 
decrease. This significant decrease in mean fractional shortening, was observed in 
all patients during bypass, (p < 0.001) Mean fractional shortening after membrane 
oxygenation was 40 % (sd 11) and showed no significant difference in comparison 
to the values for fractional shortening before bypass. 
Results in subgroups 
In 18 patients a ductal left to right shunt was demonstrated after 24-36 hour on 
membrane oxygenation. Table I and II together with figure 3A/B and 4 will 
present the mean values for diastolic and systolic left ventricular dimensions and 
fractional shortening in patients with and without a ductal left to right shunt, 
measured before, at 24-36 hours on bypass and after decanulation. In the 
"ductus"group, mean diastolic and systolic dimensions showed a significant 
increase comparable to the total group, (p < 0.05, resp. ρ < 0.0005) After bypass is 
stopped no important changes were observed in the diastolic diameter. The systolic 
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diameter however, decreased again to its original level before bypass. Looking at 
the fractional shortening in this "ductus"group before, during and after bypass, we 
measured respectively a mean value of 37% (sd 12), 16% (sd 10) and 40% (sd 13). 
Comparison between fractional shortening before and during bypass, showed also 
a significant decrease in fractional shortening (p < 0.001) in the "ductus" group 
with a mean decline of 21% (sd 13). 
Table 1. Patients with ductal left to right shunt (n=18) 
before 
24-36 
after 
mean 
DdLV 
13.3 
15.5 
14.8 
(range) 
(9.2- 17.7) 
(12.1 
(9.1-
-21.4) 
• 20.5) 
mean 
DsLV 
8.5 
13.0 
8.9 
(range) 
(3.8 - 12.5) 
(8.7-
(3.8-
• 18.8) 
• 16.2) 
mean 
FS 
36.5 
16.4 
40.1 
(rai 
(15 
(0-
(37 
ige) 
-69) 
41) 
-61) 
Table 2. Patients without ductal left to right shunt (n=ll) 
before 
24-36 
after 
mean 
DdLV (range) 
14.7 (11.0-26.9) 
16.9 (11.2-23.1) 
15.8 (12.9- 19.2) 
mean 
DsLV 
9.7 
12.3 
9.5 
(range) 
(4.8 - 18.5) 
(8.1 - 17.1) 
(6.7 - 14.7) 
mean 
FS 
35.1 
29.0 
40.3 
(range) 
(21-56) 
(16-39) 
(23 - 50) 
In the "non-ductus" group of 11 patients, the mean diastolic dimension did not 
increase significantly during bypass. Systolic dimension showed the same 
significant increase as earlier observed (p < 0.009). Fractional shortening in this 
group before, during and after bypass was calculated as respectively 35% (sd 12), 
29% (sd 7) and 40% (sd 7). The observed decrease of 6% in fractional shortening 
in these patients was not significant. 
Prior to bypass, no differences in fractional shortening were observed between the 
"ductus"group and the "non-ductus"group. On the contrary, during membrane 
oxygenation, the decrease in fractional shortening was significantly more 
pronounced in those patients who developped a ductal left to right shunt with a 
significant difference (p < 0.006). This difference in fractional shortening during 
bypass dissappeared again after bypass was terminated. Furthermore, 65% of 
patients in the "ductus"group showed a very severe decreased fractional shortening 
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Figuur 3A and 3B: Variations in mean diastolic (DdLV) and systolic (DsLV) left ventricular 
dimensions before, at 36-48 hours on and after extracorporeal membrane oxygenation in 
patients with (3A) and without (3B) a ductal left to right shunt during bypass. 
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Figuur 4: Variations in mean left ventricular fractional shortening before, at 24-36 hours on and 
after extracorporeal membrane oxygenation in patients with and without a ductal left to right 
shunt (FS = fractional shortening) 
smaller than ten percent, against 22% of patients in the "non-ductus'group. This 
difference in very severe decreased fractional shortening between the "ductus"-
and the "non-ductus"group is significant, (p < 0.05) 
Discussion 
Before extracorporeal membrane oxygenation is started the measured mean left 
ventricular diastolic and systolic dimensions are much lower in comparison to the 
left ventricular dimensions in the normal population. Other authors described 
dimensions within the same range as we observed, bud did not comment the low 
percentiles of the left ventricular dimensions in this particular patient group. 
(4,6,15) It is unclear why the left heart chamber is so small before membrane 
oxygenation. Possibly the severe pulmonary hypertension resulting in a ductal 
right to left shunt, will reduce the preload to the left ventricle in this situation. 
Also the pressure overload of the right ventricle before bypass could be of 
influence by a shift in the position of the interventricular septum. Once on bypass, 
we observed a significant increase of diastolic and systolic diameter for all 
patients. Looking in the "ductus" subgroup we found the same significant increase 
especially in diastole which was not found in patients of the "non-ductus'group. 
The observed increase in diastolic dimension in the ductus group, will illustrate the 
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volume loading to the left ventricle, once a ductal left to right shunt has 
develloped 
The left ventricular fractional shortening was not depressed before the start of 
extracorporeal oxygenation, especially when the clinical picture of the critically ill 
patients before bypass is taken into account The temporary administration of 
dopamine and dobutamine could also influence this pre-bypass phase because of 
the positive inotropic effects During bypass a drop in fractional shortening is 
noticed, possibly related to various factors such as decreased preload, post-hypoxic 
injured myocardium and reperfusion injury or increased afterload (4,6,15,16) 
Other authors have described this drop in fractional shortening and have postulated 
that the decrease in preload was responsible for the bad fractional shortening (3) 
Ofcourse left ventricular performance is also measured and monitored with 
parameters that are more insensible to the preload, such as heart-rate-corrected 
mean circumferential fiber fractional shortening (17) However, our study was 
performed to analyze the volume loading effects of a ductal left to right shunt For 
that reason we selected the fractional shortening, a preload dependent parameter 
(4), and examined whether a ductal left to right shunt will have an increasing 
effect on the fractional shortening So, a ductal left to right shunt will create a 
better preload state for the left ventricle A ductal left to right shunt will also 
influence the coronary oxygen saturation because the ductal shunt will increase the 
oxygen saturation of the blood in the left atrium and the left ventricle The oxygen 
saturation in the left atrium is usually decreased in this phase of membrane 
oxygenation because of intrapulmonary right to left shunting It has become clear, 
that the coronary perfusion is in particular determined by the antegrade flow from 
outflow tract into the ascending aorta and less influenced by the the retrograde 
flow from the aortic cannula (18) Nevertheless concerning the fractional 
shortening, we observed no preserving effect from a ductal left to right shunt 
Nakamura (10) described a better coronary oxygen saturation and perfusion when 
a small left to right shunt is present in dogs placed on extracorporeal membrane 
oxygenation On the contrary, we observed a significant decrease in the fractional 
shortening during bypass, in those patients with a ductal left to nght shunt 
Possibly, this volume loading to the left ventricle is not tolerated very well shortly 
after extracorporeal oxygenation is started In this context, an important ductal left 
to right shunt could, at the other side, decrease the coronary perfusion by stealing 
the blood in diastole from the aorta into the direction of the pulmonary artery In 
all patients the decreased fractional shortening normalized without any specific 
therapy after decannulation The duct was also closed in all these patients Holley 
et al (4) pointed out that the decrease in cardiac performance is not influenced by 
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the underlying diagnosis but mainly is determined by loading conditions. The 
ductal left to right shunt during bypass is, in general, haemodynamicaiiy important 
and will lead to pulmonary hyperperfusion that is demonstrated in the lamb (19). 
This volume loading effect is regarded to be beneficial. In contradiction to Holley 
(4), we could not observe any protecting effect from a ductal left to right shunt in 
relation to the fractional shortening. Perhaps other factors than preload are more 
important during extracorporeal membrane oxygenation, for example, the 
afterload, left ventricular wall stress or coronary artery resistance. The results of 
studies concerning these factors are somewhat conflicting. Kimball (6) pointed out 
that during bypass no significant changes in contractility or afterload were 
observed when volume load independent determinants of cardiac output were used 
(heart rate-corrected velocity of circumferential fiber fractional shortening in 
relation to wall stress and left ventricular end systolic wall stress). Berdjis et al 
(17) measured also volume load independent variabels and found no disturbances 
in contractility when corrected for afterload and suggested that there was no 
depression on myocardial function. On the contrary, Kato and co-workers 
demonstrated in dogs a decrease of coronary perfusion because of an increased 
coronary arterial resistance (20). Comparison of studies after the cardiac 
performance in veno-venous extracorporeal oxygenation make clear that 
disturbances in cardiac performance are mostly observed in veno-arterial 
extracorporeal oxygenation (4). Much more studies are neccessary to analyze and 
understand the working mechanism of the left ventricle under alterated volume-
and pressure loading conditions during extracorporeal membrane oxygenation. 
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6 Summary, conclusions and future perspectives 
Summary and Conclusions 
Critically ill neonates subjected to veno-arterial ECMO will show important 
circulatory allterations in relation to the typical signs of the fetal circulation. The 
clinical picture of "persistent pulmonary hypertension of the neonate" is present 
in almost all patients prior to ECMO and forms the "final common pathway" for 
all connected diagnosis to ECMO. The anatomic structure of the pulmonary 
vasculature in the neonate is the substrate for producing this severe pulmonary 
hypertension and for the severe elevated pulmonary vascular resistance. 
Once on ECMO, the process that decreases pulmonary blood pressure begins and 
the involved circulatory changes are interpreted as a circulatory "renaissance" 
because of the great similarity in comparison to the circulatory adaptation 
immediately after birth when fetal circulation is transformed into the neonatal 
circulation. In chapter 1, an overview is presented as introduction into the perinatal 
circulation, the disturbances and the first pioneering efforts concerning treatment. 
To monitore the disturbances in the neonatal circulation, this study was designed 
using echo-Doppler cardiography and described in chapter 2. A very early and 
important decrease in pulmonary hypertension was observed already after 12 hours 
on ECMO. This decrease in pulmonary hypertension was independently of ECMO 
flow because ECMO flow was not changed during the first 48 hours. Several 
pressure related-variabels were investigated such as the peak flow velocity of 
tricuspid- and pulmonary valve regurgitation, the peak flow velocity of the ductal 
R-L and L-R shunt and the systolic time intervals of the right- and left ventricle. 
To monitore systolic pulmonary blood pressure in relation to ECMO, pressure 
predictions derived from tricuspid valve regurgitation are preferential because of 
the high incidence of tricuspid valve regurgitation in these neonates and fare 
results in pressure prediction. Together with the drop in pulmonary vascular 
resistance, we observed an increasing number of patients up to almost 50% after 
12 hours and 30% after 24 hours on ECMO, in whom the ductal R-L shunt 
reversed into the L-R shunttype. Also this change in direction of the ductal shunt is 
independently from ECMO flow. Besides the decreasing systolic pulmonary artery 
pressures derived from peak flow velocity of the tricuspid regurgitation, the 
demonstrated reverse of the ductal shunt into the left to right form, is another 
proof of decreasing pulmonary vascular resistance. In conclusion: 
- Severe pulmonary hypertension is present in all patients and will decrease 
very early, within 12 hours during the ECMO course monitored by echo-
Doppler variables. 
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- The duct is patent in 82% of cases, the shunt initially R-L and will reverse 
into L-R mostly after 24-36 hours on ECMO. 
- During ECMO, the duct will close spontanously in almost all patients. 
In chapter 3, the clinical impact of the ductal L-R shunt on the ECMO course is 
studied Before ECMO no patients with signs of a ductal L-R shunt were found 
Almost all patients (82%) showed the R-L or bidirectional ductal shunt before 
ECMO In 18 % of the patients no shunt was demonstrated During ECMO, in 
total, the ductal L-R shunt was noticed in 62% of patients No L-R shunt was 
demonstrated in 38 % of the patients during ECMO When compared to patients 
without this ductal shunt, there was a significant longer ECMO duration of 46 
hours in the patients who showed a ductal L-R shunt during ECMO Spontanous 
closure was observed in almost all patients after 120 hours, except one patient who 
showed rebound pulmonary hypertension In the patients with the ductal L-R 
shunt, also a decrease was observed in LA/Ao ratio when the LA/Ao ratio is 
compared during and after the ductal L-R shunt period, illustrating the decrease in 
volume loading to the left heart after the duct is closed The demonstrated 
differences in ECMO duration were not due to one of the underlying diagnoses, 
especially congenital diaphragmatic hernia 
Originally the intention was to analyse the signs of volume overloading during the 
ductal L-R shunt by means of the radiological patterns of the chest X-ray, also 
known as the "typical white-out pattern" During ECMO the typical white-out 
pattern will resolve after some time possibly parallel to the disappearing ductal L-
R shunt However, it was not possible to organize a randomized observation and 
evaluation of all chest X-ray's by two independent experts in this field The 
scientific work of Taylor et al (chapter 3, reference 12) has illustrated the 
improvement of the radiological pattern together with the improvement in lung 
compliance in relation to the ductal shunt or its closure In conclusion 
Patients with a period of ductal L-R shunting during ECMO will show a 
longer ECMO duration with a mean value of 46 hours. The observed ductal 
L-R shunt will interact with the pulmonary- and renal function and interfere 
with weaning from bypass. 
Because of the impossibility to perform such a study in the neonate, the animal 
study was chosen to perform an invasive circulatory study 
In chapter 4, the ductal L-R shunt during ECMO was mimicked in an animal study 
to objectivate the shunt size and to study the relation to other haemodynamic 
parameters such as cardiac output and ECMO flow In this study the duct was 
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infiltrated with formalin to prevent closure after birth The experiment became 
possible after extensive instrumentation of pregnant ewes and also extensive 
preparation of the fetal lambs Once on ECMO, an important L-R shunt was 
noticed in 6 of 7 studied lambs with a mean shuntvolume of 354 ml/min or 82 
ml/min/kg The ductal L-R shunt will represent resp 44%, 76% and 51% of resp 
left ventricular output, ECMO flow and total systemic circulating volume The 
demonstrated shunt size is characterized as haemodynamic important and gives 
support to the hypothesis of pulmonary hypercirculation and also supports the 
hypothesis of stealing the systemic circulation Together with the results described 
in chapter 3, the clinical impact of the ductal L-R shunt during ECMO is more 
emphasized On the one hand, the increase in pulmonary blood flow will lead to 
pulmonary hyperperfusion and pulmonary edema Weaning of ECMO could be 
prohibited because of these phenomena On the other hand the duct with the L-R 
shunt will steel an important amount of blood from the systemic circulation in the 
descending aorta and will induce renal hypoperfusion that is related to the general 
predisposition to edema during the first days on ECMO Thus it is acceptable that 
a ductal L-R shunt during ECMO contributes in the origin of pulmonary- and 
general edema and so interferes with weaning possibilities These circulatory 
aspects are present during ECMO among other immune-mediated factors that also 
will have their impact on the clinical picture of patients on ECMO These "non-
cardiac"factors, however, were not examined in our study In the animal model it 
was the intention to achieve a better insight between the ductal L-R shunt and the 
renal function We tried to measure the urine production during the animal 
experiments before and after closure of the duct Unfortenately the lamb 's urethra 
has the shape of a corkscrew It was impossible to cathetenze the lamb's bladder 
So, we performed a suprapubic puncture of the bladder to measure the volume of 
urine that was produced in the several phases of the experiment However it 
appears to be very difficult to achieve a waterthight connection to the bladder 
Finally in the evaluation the differences in urine production during and after the 
ductal L-R shunt were not significant although there was an increase in 
unneproduction after the duct was closed Nevertheless, we had to refer to 
ultrasound studies in which the flow in the renal artery was decreased during the 
ductal L-R shunt In conclusion 
The ductal L-R shunt during ECMO in lambs is of haemodynamic 
importance and contributes considerable in left ventricular output, ECMO 
flow and total systemic circulation. 
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In chapter 5 the left ventricular performance during ECMO is monitored using the 
fractional shortening. Before ECMO, despite the poor clinical condition of most 
patients, the fractional shortening was normal with a mean value of 36%. All 
patients showed an important decrease in fractional shortening to a mean value of 
20% after 24-36 hours on ECMO. A gradual improvement is observed during the 
following days up to a normal fractional shortening after decannulation. Before 
ECMO, left ventricular systolic and diastolic dimensions are small. Especially in 
patients with a ductal L-R shunt during ECMO a significant increase in diastolic 
dimension is observed illustrating the volume loading to the left ventricle. 
Fractional shortening is a volume loading dependent variable. Because of the onset 
of a ductal L-R shunt early in the ECMO course with important volume loading to 
the left heart, the effects of this volume loading on the fractional shortening were 
investigated. Despite the increased left ventricular diastolic dimension , the 
fractional shortening was significant more decreased in patients with a ductal L-R 
shunt during ECMO. Also a very severe decreased fractional shortening, smaller 
than 10 %, was observed more often in the 'ductus' group. Moreover, there are 
several indications that the coronary circulation during ECMO is provided from 
the blood stream from the left ventiele into the ascending aorta. The left ventricle 
outflow will increase when a ductal L-R shunt is present but the influence of a 
ductal shunt on the coronary circulation during ECMO, needs more investigation. 
Posthypoxic myocardial injury, reperfusion injury, together with an elevated 
afterload, are most likely the causes for myocardial dysfunction during ECMO. In 
conclusion: 
Left ventricular fractional shortening before ECMO is accurate and will show 
a significant deterioration during ECMO after 24-36 hours, followed by a 
gradual improvement in fractional shortening up to normal after 
decannulation. Volume loading circumstances such as a ductal L-R shunt will 
not improve the left ventricular fractional shortening. Before ECMO, left 
ventricular diastolic and systolic dimensions are small. Especially the left 
ventricular diastolic diameter will increase after 24-36 hours on bypass in the 
'ductus'group illustrating the volume loading to the left ventricle. 
Final conclusion 
In all patients a severe pulmonary hypertension prior to ECMO is demonstrated. 
A reasonable pressure prediction from echo-Doppler derived variabels is possible 
and will give the possibility to monitor the therapeutic effect from ECMO on 
pulmonary hypertension. The ductal shunt will behave as R-L or L-R depending 
on the pressure relation between aorta and pulmonary artery. A very early 
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decrease in pulmonary hypertension is demonstrated with an early onset of ductal 
L-R shunt in patients in which the duct is patent. 
Patients who develop this ductal L-R shunt during ECMO will show a longer 
mean ECMO duration of 46 hours. We did not demonstrate the onset of a ductal 
L-R shunt together with the onset of the radiological white-out pattern. The ductal 
shunt was quantified in an animal experiment and demonstrated as an important 
L-R shunt with considerable impact on several cardiac output parameters. In the 
animal experiment we could not prove the effects of a ductal L-R shunt on 
pulmonary and renal function. 
Left ventricular fractional shortening was measured and showed an important 
decrease during ECMO. 
From the volume loading ductal L-R shunt no improving effects on fractional 
shortening during ECMO could be observed. 
Future perspectives 
This study has demonstrated that veno-arterial ECMO is an excellent treatment for 
the pulmonary hypertension in critically ill neonates. Pulmonary hypertension is 
reacting already within 12 hours of ECMO. When the reaction is so quickly it 
allows perhaps earlier weaning attempts to minimalize the number of 
complications related to ECMO and to shorten the ECMO course. 
In this context it should be desirable to draw up weaning criterions. 
Also this study showed that, an important ductal L-R shunt becomes possible after 
the pulmonary hypertension is well treated with ECMO and this shunt is possibly 
related to ECMO flow. So when pulmonary vascular resistance is low and a 
significant ductal shunt has developped, perhaps forced weaning from bypass is 
capable in reducing the ductal shunt and so reducing the pulmonary 
hypercirculation. 
Another study focused on weaning attemts in relation to low pulmonary vascular 
resistance, ductal L-R shunting and improving left ventricular function, is capable 
in analyzing the most significant conditions on which an ECMO patient has good 
propects concerning weaning from bypass. 
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Samenvatting, conclusies en aanbevelingen voor de toekomst 
Samenvatting en conclusies 
Ernstig zieke pasgeborenen welke behandeld worden met behulp van veno-
arteriele ECMO vertonen circulatoire veranderingen met het accent op de typische 
verschijnselen van de foetale bloedsomloop. Het klinisch beeld van "de 
persisterende pulmonale hypertensie van de neonaat" is bij bijna alle ECMO 
patiënten aanwezig voor dat ECMO gestart wordt en vormt een 
gemeenschappelijke pathofysiologische weg waarlangs zich het klinische beeld 
van alle aan ECMO verbonden diagnosen afspeelt. De anatomische structuur van 
de longbloedvaten en de pathofysiologische reactie van de neonaat vormen het 
substraat voor deze ernstige pulmonale hypertensie en ernstig verhoogde 
pulmonale vaatweerstand. Indien de neonaat aan ECMO wordt aangesloten, kan 
het proces beginnen dat de pulmonale bloeddruk doet dalen gepaard gaande met 
een aantal circulatoire veranderingen die beschouwd kunnen worden als een 
circulatoire wedergeboorte vanwege de grote gelijkenis van deze veranderingen 
met circulatoire veranderingen tijdens en kort na de geboorte, wanneer de 
overgang plaatsvindt van foetale naar neonatale bloedsomloop. 
In hoofdstuk 1 wordt een overzicht gegeven van de perinatale circulatie, hiermee 
samenhangende stoornissen en de eerste pogingen om deze te behandelen. 
In hoofdstuk 2 worden observaties beschreven van stoornissen in de neonatale 
circulatie in deze studie onderzocht met behulp van echo-Doppler 
echocardiographie. Een snelle en belangrijke daling van de pulmonale bloeddruk 
werd aangetoond reeds na 12 uur ECMO behandeling. Deze daling in pulmonale 
bloeddruk was onafhankelijk van de ECMO flow aangezien deze gedurende de 
eerste 48 uur constant gehouden werd.Verschillende druk-afgeleide variabelen 
werden onderzocht zoals, maximale stroomsnelheden van tricuspidalis- en 
pulmonalisklepinsufficientie, maximale stroomsnelheden van ductale R-Len L-R 
shunt en de systolische tijdsintervallen van de rechter en linker hartkamer. Om de 
systolische bloeddruk in de longslagader te bepalen en deze tijdens ECMO te 
kunnen vervolgen lijken bloeddrukvoorspellingen gebaseerd op de maximale 
leksnelheid van de tricupidalisklep het meest aan te bevelen vanwege de 
acceptabele resultaten en de hoge incidentie van tricuspidalisklepinsufficientie in 
deze populatie. De bovenvermelde daling van de pulmonale bloeddruk reeds na 12 
uur ECMO behandeling gaat samen met een tegelijkertijd optredende omslag van 
een ductale R-L shunt in een L-R shunt. Na 12 uur ECMO behandeling, wordt bij 
bijna 50% van de neonaten een ductale L-R shunt waargenomen en na 24 uur ECMO 
behandeling 30% L-R shunt. Ook deze omslag in shuntrichting is onafhankelijk van 
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de ECMO flow aangezien deze gedurende de eerste 48 uur constant gehouden werd. 
Naast de reeds aangetoonde daling van de pulmonale bloeddruk tijdens ECMO is de 
omkering van een ductale R-L shunt in een L-R shunt ook een bewijs van de dalende 
pulmonale vaatweerstand tijdens ECMO behandeling. 
In conclusie betreffende hoofdstuk 2: 
- Ernstige pulmonale hypertensie is aanwezig in alle patiënten en deze zal, 
gemeten en vervolgd met behulp van echo-Doppler variabelen snel dalen ( < 12 
uur ) na de start van ECMO behandeling. 
- De ductus Botalli is open bij 82 % en de shunt richting, aanvankelijk R-L zal in 
de meeste gevallen binnen 24-36 uur na ECMO behandeling omkeren in een 
L-R shunt. 
- Spontane sluiting van de ductus Botalli tijdens ECMO wordt in bijna alle 
patiënten waargenomen. 
In hoofdstuk 3 wordt de invloed bestudeerd van een ductale L-R shunt op het 
klinische beloop van de ECMO behandeling. Vóór de start van ECMO wordt in 82 
% een ductale R-L shunt of bidirectionele shunt aangetoond. Bij 18 % kon geen 
ductale shunt worden gevonden. Uiteindelijk doet zich een ductal L-R shunt voor 
in 62 % tijdens ECMO behandeling. In 38 % kan tijdens ECMO deze shunt niet 
worden aangetoond. Een significant langere ECMO duur van gemiddeld 46 uur 
kon worden bewezen in patiënten met een ductale L-R shunt tijdens de ECMO 
behandeling. Spontane sluiting na 120 uur ECMO behandeling was regel met 
uitzondering van 1 patient waarbij een rebound pulmonale hypertensie optrad. De 
volumebelasting van het linker hart bij patiënten met een ductale L-R shunt kon 
worden geïllustreerd aan de hand van een afname in LA/Ao ratio na spontane 
sluiting van de ductus Botalli. De in dit hoofdstuk aangetoonde verschillen in 
totale ECMO duur kon niet worden geweten aan de onderliggende diagnose, in het 
bijzonder de hemia diaphragmatica. Oorspronkelijk was het binnen de 
onderzoeksopzet de bedoeling de volumebelasting ten gevolge van de ductale L-R 
shunt te analyseren door het typische röntgenologische "white-out"effect op de 
thoraxfoto te graderen en te vervolgen tijdens ECMO behandeling. Echter, het 
bleek niet mogelijk een gerandomiseerde onafhankelijke expertise te organiseren. 
Het wetenschappelijk werk van Taylor (hoofdstuk 3 referentie 12) vermeldt 
simultane verbetering van de thoraxfoto met het sluiten van de ductus Botalli en 
het verbeteren van de longcompliantie. 
In conclusie betreffende hoofdstuk 3: 
- Een ductale L-R shunt tijdens ECMO behandeling gaat gepaard met een 
significant langere ECMO duur met een gemiddelde verlenging van 46 uur. 
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- De ductale L-R shunt zal de longcompliantie kunnen beïnvloeden en als 
zodanig interfereren met ontwenning van ECMO. 
Om een invasieve circulatoire studie te verrichten moest uitgeweken worden naar 
een diermodel vanwege de onmogelijkheden zo'n studie uit te voeren in de patient. 
In hoofdstuk 4 wordt de opzet van een diermodel beschreven teneinde een ductale 
L-R shunt na te bootsen , deze te kwantificeren en de relatie met andere 
haemodynamische parameters te bestuderen, zoals cardiac output en ECMO flow. 
Het dierexperiment werd pas mogelijk na uitgebreide instrumentatie van zwangere 
ooien en foetale lammeren. De ductus Botalli werd geïnfiltreerd met formaline om 
sluiting te voorkomen. In 6 van de 7 lammeren kon een belangrijke ductale L-R 
shunt worden aangetoond tijdens ECMO met een gemiddeld L-R shunt van 354 
ml/min. of 82 ml/min/kg. De L-R flow percentages voor wat betreft vergelijking 
met de linker ventrikel output, ECMO flow en totaal circulerend volume werden 
berekend op resp. 44%, 76% en 51%. De aangetoonde L-R shunt kon als 
haemodynamisch belangrijk worden aangemerkt en ondersteunen de 
oorspronkelijke hypothese waarin de ductale L-R shunt enerzijds bijdraagt aan het 
onstaan van een pulmonale hypercirculatie en anderzijds ten koste zal gaan van de 
circulatie in de aortaboog distaal van de ductus Botalli. De resultaten van 
hoofdstuk 4 in samenhang met die van hoofdstuk 3 maken de klinische 
importantie van een ductale L-R shunt meer inzichtelijk. Zoals gezegd ontstaat een 
situatie van toegenomen longflow en longoedeem, waardoor ontwenning van 
ECMO bemoeilijkt kan worden. Anderzijds zal de hoeveelheid bloed welke door 
de L-R shunt naar de longcirculatie stroomt, ten koste gaan van de 
bloeddoorstroming distaal van de ductus botalli en leiden tot renale hypoperfusie 
welke aanleiding kan geven tot oedeem gedurende de eerste dagen aan ECMO. 
Deze circulatoire aspecten van een ductale L-R shunt tijdens ECMO spelen een rol 
temidden van een aantal andere meer door immuun-activatie bepaalde factoren 
welke ook oedeem en longoedeem kunnen verklaren. Deze niet-cardiale oorzaken 
zijn in dit onderzoek door ons niet onderzocht. In het diermodel zijn pogingen 
ondernomen een beter inzicht te verkrijgen in de relatie tussen ductale L-R shunt 
en de unneproductie. Echter onmogelijkheden om nauwkeurig de urineproductie te 
meten in lammeren (lammeren hebben een urethra in de vorm van een 
kurketrekker) hebben wel geleid tot een stijging van de urineproductie nadat de 
ductus Botalli was gesloten, maar de verschillen waren niet significant. Referenties 
naar ultrageluidsstudies welke een daling van de renale bloedflow weergeven 
tijdens een ductale L-R shunt zijn toegevoegd aan hoofdstuk 4. 
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In conclusie hoofdstuk 4: 
- De ductale L-R shunt tijdens ECMO is van haemodynamisch belang. 
- Ten opzichte van cardiac output, ECMO flow en totaal circulerend volume zal 
de ductale L-R shunt aanzienlijk interfereren. 
In hoofdstuk 5 werd een observatie verricht van de linker ventrikel functie 
gemeten aan de verkortingsfractie. Vóór ECMO, vertonen de meeste patiënten een 
normale verkortingsfractie ondanks de zeer ernstig zieke situatie waarin zij zich 
bevinden. Gemiddeld bedroeg de verkortingsfractie 36%. Alle patiënten laten een 
daling zien van de verkortingsfractie tijdens ECMO naar gemiddeld 20% na 24-36 
uur ECMO behandeling. Nadien doet zich een geleidelijke verbetering voor 
gedurende de daarop volgende dagen tot aan een normale verkortingsfractie na 
decannulatie. Vóór ECMO bestaan er opvallend kleine systolische en diastolische 
diameters van de linker hartkamer. Met name bij patiënten met een ductale L-R 
shunt wordt een toename gezien van de diastolische diameter als uiting van een 
volumebelasting. Verkortingsfractie is een variabele welke gevoelig is voor 
volumeveranderingen. De ductale L-R shunt zal door de volumebelasting van de 
linker kamer , de preload van de linker kamer verbeteren met name tijdens ECMO 
behandeling. Dit zou kunnen leiden tot een betere verkortingsfractie bij patiënten 
met een ductale L-R shunt. Echter in ons onderzoek kon geen verbetering in 
verkortingsfractie worden aangetoond in patiënten met een ductale L-R shunt 
tijdens ECMO. Integendeel de verkortingsfractie in patiënten met een ductale L-R 
shunt was significant slechter. Ook werden extreem lage verkortingsfracties ( < 
10% ) veel vaker waargenomen in deze groep. Doordat de coronaire circulatie 
tijdens ECMO met name wordt verzorgd door antegrade bloedstromen vanuit de 
linker hartkamer en niet door de retrograde stromen van de aorta canule, kan een 
ductale L-R shunt hier invloed op hebben. Posthypoxische myocardschade en 
reperfusie schade in combinatie met verhoogde afterload lijken de belangrijkste 
oorzaak voor linker hartkamer dysfunctie tijdens ECMO. 
In conclusie hoofdstuk 5: 
- Linker hartkamer verkortingsfractie vóór ECMO is ongestoord en toont een 
significante achteruitgang na 24-36 uur ECMO behandeling gevolgd door een 
geleidelijk herstel tot volledige normalisatie na decannulatie. 
- Volume belasting door een ductale L-R shunt geeft niet de te verwachten 
verbetering in verkortingsfractie. 
- Vóór ECMO zijn de diameters van de linker hartkamer klein, zowel systolisch 
als diastolisch. Vooral bij patiënten met een ductale L-R shunt tijdens ECMO 
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wordt een toename gezien van de diastolische diameter passend bij een 
volumebelasting voor de linker hart kamer. 
Samenvattende eindconclusies 
In alle patiënten die in aanmerking komen voor ECMO behandeling is een ernstige 
pulmonale hypertensie aantoonbaar vóór aanvang van deze behandeling. Predictie 
van de bloeddruk in de longslagader is op acceptabele wijze mogelijk met behulp 
van echo-Doppler variabelen en geeft de mogelijkheid de bestaande pulmonale 
hypertensie te vervolgen tijdens de ECMO behandeling en als zodanig het 
therapeutisch effect van ECMO te evalueren. Afhankelijk van de 
bloeddrukverhoudingen tussen enerzijds de aorta en anderzijds de longslagader, 
zal bij open ductus Botalli de shuntrichting R-L, bidirectioneel of L-R zijn. Een 
zeer vroege en snelle daling van de pulmonale hypertensie werd aangetoond met 
een vroege omdraai ng van de ductale shunt in die patiënten waarbij de ductus 
open is. Deze patiënten met een ductale L-R shunt tijdens de ECMO behandeling, 
vertonen een langere totale ECMO duur van gemiddeld 46 uur. Het samengaan 
van deze ductale L-R shunt met het typische radiologische "white-out"aspect op 
de thoraxfoto werd door ons niet onderzocht. 
Kwantificering van de ductale L-R shunt tijdens ECMO behandeling werd verricht 
in een ECMOmodel bij lammeren. De shunt werd haemodynamisch als belangrijk 
gekarakteriseerd in samenhang met andere haemodynamische parameters. Binnen 
dit diermodel konden de effecten van de ductale shunt op long- en nierfunctie om 
technische redenen niet geheel worden bepaald. De functie van de linker 
hartkamer gemeten met behulp van de verkortingsfractie laat tijdens ECMO 
behandeling een belangrijke afname zien. Aangezien de verkortingsfractie van de 
linker hartkamer voor een belangrijk deel volume bepaald is, werd de invloed van 
een door de ductale L-R shunt geïnduceerde volumebelasting geanalyseerd. Een 
verbeterende invloed op de verkortingsfractie kon niet worden aangetoond, 
integendeel bij patiënten met een ductale L-R shunt tijdens ECMO werd een 
significant lagere verkortingsfractie gevonden. 
Aanbevelingen voor de toekomst 
Deze studie heeft aangetoond dat ECMO een uitstekende behandeling is voor 
patiënten met ernstige pulmonale hypertensie. Deze pulmonale hypertensie daalt al 
snel tijdens de behandeling. Gezien deze vlotte respons is het misschien mogelijk 
de patient eerder en vlotter te ontwennen van de ECMO machine om met deze 
behandeling samenhangende complicaties te kunnen reduceren en de ECMO duur 
te verkorten. Binnen dit kader zou het belangrijk kunnen zijn criteria op te stellen 
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voor ontwenning van de ECMO machine en deze te toetsen. Daarnaast is het de 
vraag of, indien zich tijdens ECMO een ductale L-R shunt voordoet, geforceerde 
ontwenning therapeutische voordelen heeft aangezien de ductale shunt versterkt 
kan worden door de ECMO flow in de aorta ascendens, om zo een bepaalde mate 
van pulmonale hypercirculatie te reduceren. 
Een toekomstige studie die zich bezig houdt met ontwennen van de ECMO 
machine binnen de voorwaarden van lage pulmonale weerstand, ductale L-R 
shunting en een betere linker hartkamerfunctie zou die condities kunnen aantonen 
waaronder een ECMO patient optimaal behandeld wordt. 
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Stellingen 
behorend bij het proefschrift 
Cardiac and circulatory effects of patent ductus arteriosus 
during extracorporeal membrane oxygenation. 
- Daling van de pulmonale hypertensie bij de pasgeborenen treedt tijdens ECMO 
veel sneller op dan tot nu toe bekend was. (dit proefschrift) 
- De ductale L-R shunt tijdens ECMO treedt vaker op en is belangrijker dan 
oorspronkelijk verondersteld werd. (ditproefschrift) 
- Een ductale L-R shunt tijdens ECMO behandeling leidt tot een belangrijke 
verlenging van de totale ECMO duur. (dit proefschrift) 
- De afname in verkortingsfractie van de linker hartkamer tijdens ECMO kan niet 
alleen maar verklaard worden door een afname van de preload, (dit proefschrift) 
- Naast peak velocity metingen van tricuspidaalklep lekkage zijn peak velocity 
metingen in de ductale shunt ook geschikt voor het vervolgen van pulmonale 
hypertensie tijdens ECMO. (dit proefschrift) 
- Bij de organisatie en het uitvoeren van proefdieronderzoek moet rekening 
gehouden worden met de invloed van besmettelijke ziekten in de intensieve 
nederlandse bio-industrie, (eigen ervaring) 
- Proefdieronderzoek is eerder acceptabel indien binnen hetzelfde diermodel 
meerdere onderzoekers of experimenten participeren, (eigen ervaring) 
- Gelet op de salariëring van medisch specialisten met vergelijkbare werkbelas-
ting geldt voor een groot aantal dat er eerder sprake is van een maandelijkse 
belediging dan een maandelijkse bevrediging. 
- De vier wielen onder een echocardiograaf zijn in de ogen van de ARBO-dienst 
veel eerder een rem. 
- De kerstroos is geen roos en bloeit ook niet met Kerstmis. (R. v.d. Kaa) 
- Het aantal volwassenen met een aangeboren hartafwijking in onze maatschappij 
zal het aantal kinderen met deze afwijking vele malen gaan overtreffen. 
Beek-Ubbergen, 4 juli 2003 Ronald Tanke 
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